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With the revolutionary progress in sequencing technologies, computational biology 
emerged as a game-changing field which is applied in understanding molecular events of 
life for not only complementary but also exploratory purposes. Bioinformatics resources 
and tools significantly help in data generation, organization and analysis. However, there 
is still a need for developing new approaches built based on a biologist’s point of view. In 
protein bioinformatics, there are several fundamental problems such as (i) determining 
protein function; (ii) identifying protein-protein interactions; (iii) predicting the effect of 
amino acid variants. Here, I present three chapters addressing these problems from an 
evolutionary perspective. Firstly, I describe a novel search pipeline for protein domain 
identification. The algorithm chain provides sensitive domain assignments with the 
highest possible specificity. Secondly, I present a tool enabling large-scale visualization 
of presences and absences of proteins in hierarchically clustered genomes. This tool 
visualizes multi-layer information of any kind of genome-linked data with a special focus 
on domain architectures, enabling identification of coevolving domains/proteins, which 
can eventually help in identifying functionally interacting proteins. And finally, I propose 
an approach for distinguishing between benign and damaging missense mutations in a 
human disease by establishing the precise evolutionary history of the associated gene. 
This part introduces new criteria on how to determine functional orthologs via 
phylogenetic analysis. All three parts use comparative genomics and/or sequence 
analyses. Taken together, this study addresses important problems in protein 
bioinformatics and as a whole it can be utilized to describe proteins by their domains, 
coevolving partners and functionally important residues.  
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The genomics era was started in 1995 by a group led by Craig Venter who published the 
complete DNA (genome) sequence of Haemophilus influenza (Fleischmann et al. 1995; 
Cristianini and Hahn 2006). It was the first sequenced genome of a free-living organism. 
Venter’s method of genome assembly, shotgun sequencing, opened the doors for 
inevitable genomic data accumulation. In the following year, the first eukaryotic genome 
(Saccharomyces cerevisiae) was published (Goffeau et al. 1996). Year by year, DNA 
sequencing became easier and cheaper.  After only 5 years, the human genome was 
sequenced (Venter et al. 2001). Today, researchers (from the United States and China in 
parallel) aim to sequence 1 million human genomes in the next few years (Stephens et 
al. 2015).  
With the revolutionary developments in sequencing technologies and instrumentation, 
genomic data has been accumulating exponentially (Figure 1-1). So far, the amount of 
genomic data has doubled every 7 months since 2008 which has significantly beaten the 
curve of Moore’s law (doubles every 18 months) (Stephens et al. 2015).  As of August 
2015, the number of sequenced (partially/fully) genomes in the NCBI genome database 
approached 50,000. Though gaining more information on living beings, including humans, 
sounds like a great advancement, the ability to understand the data remains a growing 
challenge. Since generated raw sequence data alone is not useful to infer information, 
unprocessed sequence data needs to be compiled and converted into a format that 
addresses certain questions of interest. This data-processing is performed with 
specialized tools through scientific measurement methods. Bioinformatics, which is partly 
the field of designing tools and approaches for retrieving, storing, organizing, visualizing 
and analyzing biological data, is vital for scientists desiring to know about their 
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DNA/protein sequence of interest (Luscombe et al. 2001). New knowledge derived from 
living beings can be obtained by using the services offered by the bioinformatics field. 
However, making sense out of large series of letters (DNA or protein sequences) is 
challenging. As the interpretation of large data depends on computational capabilities, the 
fields of computational biology and bioinformatics are continuously expanding since the 
beginning of the exponential growth of biological data. Research in these fields attracted 
attention due to promising results for prognosis, diagnosis and treatment of diseases 
(Mount 2001).  
There are three aims of bioinformatics (Kumar and Dudley 2007). The first aim is to 
develop systems to store data, so that it is accessible to researchers. Because automated 
algorithms are erroneous, manual curation is important (Howe et al. 2008). However, 
manual curation is a limiting step and tends to fall behind of the growth of genomic data. 
Though automated systems are still not at the desired level of precision, as our 
understanding of molecular biology expands, the quality of these resources increases. 
For instance, the partially manually-curated protein database RefSeq has not shown a 
steeper rate of increase especially in the last few years (Figure 1-2). The second aim is 
to develop tools, methods and resources helping biologists to convert data to knowledge. 
Because the majority of researchers conducting experimental work are not data 
scientists, user-friendly tools are needed (Kumar and Dudley 2007). The increasing rate 
of genomic data has surpassed computational developments. Therefore, algorithms that 
are specifically designed for genomic data should be developed and implemented to 
maintain an efficient computation for a desired task. Bioinformatics tools and resources 




The data retrieved from GenBank. 
 
Figure 1-1 Genomic data growth in GenBank.  
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to address specific questions of interest. Finally, the third aim is to apply these resources 
in data analysis in order to infer biologically meaningful results. This dissertation serves 
promote to the last two aims of bioinformatics with attempts to understand proteins from 
an evolutionary perspective. As a subfield of biology, evolutionary bioinformatics focuses 
on understanding mutative events at the levels ranging from molecules to populations, by 
applying computational methods. This work concentrates on protein evolution at not only 
a molecular but also a genomic level. 
1.1 Biology overview 
1.1.1 Central dogma of molecular biology: DNA to protein 
The genome of a free-living organism is composed of DNA (deoxyribonucleic acid) which 
carries the heritable information. DNA is in double-helix conformation (Watson and Crick 
1953) and each strand is composed of a linear sequence of deoxyribonucleotides: 
adenine (A), thymine (T), guanine (G) and cytosine(C). A and G (purines) pair with T and 
C (pyrimidines), respectively, through hydrogen bonding (Donohue and Trueblood 1960). 
Due to this complementarity the sequence of a single strand is sufficient to determine the 
sequence of the complementary strand.  
Originally described by Francis Crick in 1958, the central dogma of molecular biology 
explains the flow of information residing on biopolymers of DNA, RNA (ribonucleic acid) 
and protein in a residue-by-residue fashion (Figure 1-3) (Crick 1958; Crick 1970). 
Although the rule oversimplifies complex biological information transfer, it is useful to 





Figure 1-2 The logarithmic growth of GenBank and RefSeq databases.  
As it is manually curated, the RefSeq database is harder to construct. However, in the few last 
years, there was an increase in the number of records in RefSeq. This rate of increase exceeded 
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In protein synthesis, the first step is to construct messenger RNA (mRNA) from a genomic 
DNA template (complementary strand) in a process called transcription. RNA polymerase 
starts mRNA synthesis by binding an upstream region (promoter) of the gene. This 
binding is usually aided by proteins called transcription factors. RNA polymerase reads a 
single strand of DNA and synthesizes RNA in 5’  3’ direction. The mRNA sequence is 
identical to the coding strand (complementary to the template strand) except for uracil (U) 
in place of thymine (T). 
In eukaryotes, most genes include regions that do not code for protein. These regions are 
called introns. Right after eukaryotic transcription the mRNA (often called pre-mRNA) 
contains both coding regions (exons and introns). However, the pre-mRNA is processed 
and intron regions are excluded by joining exons. This process is called RNA splicing 
(Figure 1-4). During splicing, some of the exons can be skipped and various 
combinations of exons (while keeping the order intact) result in unique mature mRNA 
products. As the name alternative splicing implies, this process eventually results in 
different protein products (isoforms) coded by the same gene. Eukaryotic transcription 
and splicing take place in the nucleus and mature RNA are then transferred to the 
cytoplasm. 




Copied from National Human Genome Research Institute. 
 
 
In eukaryotes, after mature mRNA is produced, mRNA is transported from the nucleus to 
the cytoplasm. Here, a complex protein/RNA structure, the ribosome, facilities information 
transfer from mRNA to protein. This process is called translation. In eukaryotes, first, the 
ribosome binds to the untranslated region (UTR) of mRNA at the 5’ end. Then, the mRNA 
is scanned in a 5’  3’ direction to search for the start signature of three letters: AUG 
(start codon). mRNA in a 5’  3’ direction corresponds to an N terminus to C terminus 
directionality in proteins. The mRNA sequence is translated into an amino acid sequence 
in protein synthesis. Each 3-letter nucleotide block of RNA (codon), codes for a 
corresponding amino acid. The 4 nucleotides, A, G, U and C can generate 64 (43) different 
codons (Figure 1-5). 3 codons (UAG, UAA and UGA) do not code for amino acids, as 
they are stop codons. Protein synthesis stops when a ribosome encounters any stop 
codon. 





Figure 1-5 Codon wheel and single letter codes for amino acids.  
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After translation, a polypeptide chain (primary protein structure) is folded into a three-
dimensional structure (Figure 1-6). First, certain segments of protein are folded into 
general structural elements (secondary structures: alpha helix or beta sheet). Then, 
physical attractions between secondary structural elements result in more folding which 
eventually results in tertiary protein structure. Tertiary structures of the same protein can 
come together and form a complex (oligomer). This complex is called quaternary protein 
structure. Protein folding is primarily determined by the amino acid sequence itself. 
External factors such as solvent properties, temperature, and other aiding proteins also 
play important roles in folding. Because the structure of a protein is directly related to the 
function, deficiency in folding causes function disruption.  
Three-dimensional protein structures are composed of one or more functional units called 
domains (Figure 1-7). Domains are minimal functional and structural elements of proteins 
that can fold autonomously and evolve independently from the rest of protein as they are 
found in various domain arrangements in proteins.  
1.1.2 Mutations 
A mechanism exists that can make permanent and heritable changes to DNA, thus 
allowing genetic diversity and speciation. These changes can be due to environmental 
factors, viruses and transposable elements, and erroneous replication where DNA 
polymerases make errors. DNA polymerase makes errors at a certain rate and most of 
them are corrected by molecular proof-reading mechanisms (Reha-Krantz 2010). 
Uncorrected DNA changes are called mutations. DNA mutation and recombination are 




Copied from National Human Genome Research Institute. 




A Dicer protein contains three domains and a linker. Green: RNase III domain, yellow: PAZ 
domain, red: platform domain. The linker is shown as blue. 
 
 
responsible for many genetic disorders. Mutations can be classified in two general 
categories: (i) substitution and (ii) indel (insertion or deletion).  
Mutations accumulate in non-coding regions at an incomparably high rate relative to 
coding regions. Because of their relatively low importance in protein function, there is no 
eliminating selection pressure on these regions. However, some regions are critical in 
protein synthesis such as promoters, enhancers and silencers which play roles in protein 
expression. These regions are less prone to accumulate mutations compared to other 
non-coding regions because of their vital roles that are conserved for survival. Mutations 
in coding regions are less tolerable and thus less frequently observed than non-coding 
Figure 1-7 Example of a multi-domain protein.  
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variations. There are several types of substitution mutations within a coding region 
(Figure 1-8). First, a single nucleotide mutation resulting in a different codon that still 
encodes the original amino acid is called a synonymous or silent mutation. Synonymous 
mutations are mostly tolerable because the change doesn’t affect protein sequence and 
thus structure and function. Secondly, missense mutations cause single amino acid 
replacement on the protein and can affect protein folding, catalytic activity, and interaction 
with other molecules. Some missense mutations can be neutral and have no effect on 
protein function while others can slightly or severly change protein activity. Finally, non-
sense mutations change amino acid-encoding (sense) codons to stop (nonsense) codons 
where protein synthesis is forced to terminate early. The truncated polypeptide chains are 
usually non-functional. Beside substitutions, indels are also important in protein function. 
DNA polymerases might skip reading one or more nucleotides on the template, which 
causes deletion in the newly synthesized DNA. On the contrary, these enzymes may also 
add extra nucleotides while copying DNA, resulting in insertion. Indels are more likely to 
affect protein function if the length of indel is not a multiple of three (size of codons). This 
changes the codons read during translation, resulting in a meaningless protein sequence. 
This type of indel mutation causes a shift of the open reading frame called a “frame-shift” 
mutation.  
In diploid organisms such as humans, every gene has two copies (alleles), one on each 
pair of chromosomes. Alleles can be identical or different in terms of sequence. For a 
specific trait, if alleles result in the same observation (phenotype) the genetic condition of 
alleles is called homozygous. If alleles yield different proteins for a certain trait then they 





Adapted from National Human Genome Research Institute. 
  
Figure 1-8 Types of single point mutations.  
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If one of the alleles in a diploid organism causes a defective protein due to a mutation 
while the other allele codes for a functional protein, there are three possible 
consequences: (i) protein function is complemented by the protein coded by the wild-type 
allele (functional allele is dominant to the defective one), (ii) the deficiency in one allele 
results in insufficient amount of fully functional protein, so the overall function remains 
deficient (defective allele is dominant), (iii) the lack of protein amount partially affects 
protein function (partial dominance or haploinsufficiency).    
There are rare and common variants in a population. Simple Mendelian diseases and 
novel genetic disorders are mostly caused by rare variants. Genetic variants in a 
population are called polymorphisms. Although polymorphisms are usually benign, some 
of them have been found to be associated with diseases (Satake et al. 2009), especially 
certain combinations of single nucleotide polymorphisms (SNPs)  (De Gobbi et al. 2006).   
1.1.3 Molecular evolution 
Gene duplication is the major mechanism in the formation of new functions in evolution 
(Ohno 2013).  Gene duplication occurs via several molecular events such as unequal 
crossing-over, DNA polymerase slippage, retrotransposable elements and non-
disjunction during meiosis (Ohno 2013). When a gene is copied, an identical gene can 
keep the function if it was necessary for the organism and fixed in the population. 
However, the other copy remains redundant at first and prone to change and 
accumulation of mutations. Over generations, this copy may diverge and result in three 
possible consequences: It is (i) lost because the sequence doesn’t constitute a 
meaningful biomolecule; (ii) neo-functionalized and gains a new function; (iii) sub-
16 
 
functionalized and takes on a subset of functions of the original gene (Lynch and Conery 
2000).  
Most gene families are enlarged due to gene duplication. Genes and proteins that share 
a common ancestor are called homologs. If the homology is achieved through gene 
duplication within a current or ancestral species, homologous genes are called paralogs. 
Homologous genes in different species that evolved by a speciation event are termed as 
orthologs. Orthologs are more likely to conserve their function while paralogs are not 
anticipated to keep the identical function (Taylor and Raes 2004). 
Natural selection is a key principle in evolution and well reflected at the molecular level. 
Genes that are not vital for survival keep changing until they are either lost or modified 
enough to gain a new function. We see the same trend in amino acid sequences. Some 
residues are critical and cannot be replaced by any other amino acid while others are 
unimportant for function and structure, so they can be replaced by other amino acids. 
Amino acids sharing a common physicochemical property which is needed in a particular 
sequence position of a protein are likely to substitute each other (Figure 1-9).  
1.2 Problem overview and motivation 
Despite a steep increase in genomic data accumulation, there is still a vast amount that 
is unknown about the molecular biology of proteins. Particularly, functions of proteins are 
questions of interest. In order to establish the precise function of a protein, its interactions 
at a cellular level and physical properties at a molecular level must be determined. 
Although wet-lab experiments are informative and essential to produce basal data from 






are not practical to be applied on a large scale. For this reason, there has been a tendency 
to computationally predict protein function. In order to determine the general function of 
a protein, it should first be described based on the sequence content. Computational 
prediction of protein function at the cellular level depends on two major approaches; (i) 
homology-based; (ii) context-based. A homology-based method uses a comparative 
approach and finds similar proteins whose functions are known. If the similarity between 
“unknown” and “known” proteins is significant, then a prediction of the protein function 
can be made. However, for non-significant similarity there is still a good chance of 
predicting protein function. Remote homologs share low sequence identity, but they carry 
signatures of general properties of protein domains. For this reason, protein domains are 
computationally predicted. Determining domains in a protein gives insight about the 
overall function and potential interacting partners. However, determining protein domains 
Figure 1-9 Physiochemical properties of amino acids.  
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is a challenge. There are specific and sensitive tools available. The problem is that 
specific tools miss domains, while sensitive tools yield an undesired number of false 
positives. In addition, sensitive tools are computationally intensive and, therefore, they 
are not applicable for large-scale analyses. Consequently, there is a need for an 
optimized approach in domain prediction to reach the highest possible confidence while 
increasing sensitivity. 
Content-based protein function prediction is computationally performed by three 
methods: (i) Co-location; (ii) gene fusion and (iii) genomic co-occurrence (Aravind 2000). 
Genomic co-location is highly successful in prokaryotes because of the presence of gene 
clusters (operons) in which genes are regulated together. However, this method is not 
applicable in eukaryotes because of dispersed locations of interacting genes. Gene fusion 
is another indicator of interacting genes and proteins. If two or more genes are fused and 
yield a single protein product in a single organism, it indicates that these proteins are 
likely to interact in other systems when they are independently located in the genome. 
Finally, genomic co-occurrence is another indicator of potentially interacting proteins. If 
two genes/proteins evolve together (they are lost or kept in the genome together), it is 
likely that they are interacting at least functionally if not physically. This interaction 
information provides an important understanding about protein function. However, neither 
gene-fusion nor co-occurrence patterns is straightforward to discover. A major challenge 
in these analyses is the uncertainty about the absence of biomolecules. Proving true 
negative in genomic context is not an easy task. However, consistent observation of 
independent co-absences of genes/proteins would add a confidence. Hence, there is a 
19 
 
need for a platform to visualize co-occurrence patterns of protein and domain families to 
reveal gene fusions and interacting partners. 
Even if the overall function of a protein is established, predicting the molecular function 
of each residue is as critically important. Establishing function of specific residues is 
important for health and disease in terms of drug design, personalized medicine, and 
variant outcome prediction. Although knowing specific functions for each amino acid in a 
protein remains a big challenge, it is possible to weigh their importance in the overall 
function by evaluating their evolutionary history. By comparing homologous proteins from 
different species, it is possible to observe which amino acid was conserved and likely to 
be important and which position was less conserved so that it was replaced by other 
amino acids in its evolution. There are automated tools performing this task; finding 
similar protein sequences and comparing each position to assess their weight by 
evolution. This is a commonly used approach for also predicting damaging and benign 
mutations for human health and disease. However, the automated tools do not 
discriminate between orthologs and paralogs. Orthologs are expected to keep the 
function while paralogs are divergent copies with potentially different functions despite 
being homologs. Usually, only one of the paralogs is associated with a disease in the 
same organism for Mendelian disorders. Furthermore, automated algorithms usually 
result in an approximation when they build an evolutionary history of a gene. This 
generalization can be disadvantageous when dealing with proteins with distinct 
evolutionary histories. For these reasons, there is a need for an approach to establish 
correct evolutionary parameters and separate orthologs from paralogs in evaluating the 
evolutionary importance of each amino acid position of a protein. 
20 
 
1.3 Scope of dissertation 
This dissertation focuses on the molecular understanding of proteins from an evolutionary 
aspect. The presented work attempts to address three questions: (i) What is the function 
of a protein; (ii) Which proteins functionally interact with each other; (iii) What is the impact 
of each amino acid for protein function. 
Chapter One briefly introduces basic biology and explain the problems which were 
addressed in this work. Chapter Two describes the tools, resources and concepts that 
are important for understanding the rest of the dissertation. Additionally, Chapter Two 
also discusses the status quo of protein domain exploration and missense mutation 
outcome prediction. Chapter Three covers an approach for domain identification along 
with a web-based tool, CDvist. The rationale, approach, and algorithm are briefly 
explained in this chapter. In Chapter Four, another tool, Aquerium, for phylogenetic 
profiling visualization is introduced. The web-server also offers a resource for protein 
domain architecture investigation. In Chapter Five, a rationale for the importance of 
revealing precise evolutionary history of proteins in health and disease is established with 
a case study. This chapter proposes new criteria in distinguishing orthologs from paralogs 
with a phylogenetic approach by using the NPC1 gene which is responsible for a 
neurodegenerative genetic disorder: Niemann-Pick type C.  Moreover, this chapter 
describes an algorithm and defines new parameters in missense mutation effect 
prediction. In Chapter Six, the dissertation is summarized and applications of this work 
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This chapter summarizes the current literature on technical concepts, which are crucial 
to prepare the ground for the following chapters.  
2.1 Sequence Databases 
As discussed in the previous chapter, the first aim of bioinformatics is to store and 
organize the genomic data. Accumulating sequence data should be publicly available and 
easily accessible to researchers in order to increase the rate of biological discoveries. 
There were parallel attempts in storing and presenting annotated nucleic acid sequence 
data. Three major resources for nucleotide sequence data are: 
i. ENA (European Nucleotide Archive) maintained by EBI (European 
Bioinformatics Institute) 
ii. GenBank  maintained by NCBI (National Center for Biotechnology Information)  
iii. DDBJ (DNA Data Bank of Japan) maintained by NIG (National Institute of 
Genetics) 
These three databases are in collaboration (International Nucleotide Sequence Database 
Collaboration) and share a spectrum of raw nucleotide data (Brunak et al. 2002). 
Therefore, in principle, nucleic acids records submitted to any of the databases above 
should be available through any one of three databases.  
The same approach is applied for protein sequences as well. Although many proteins 
have been experimentally characterized, hundreds of them will never be characterized in 
laboratories. Therefore, accurately annotated and well-organized protein sequence 
databases are important for biologists. There are two centers leading and maintaining 
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protein sequence databases: EMBL (European Molecular Biology Laboratory) and NCBI. 
EMBL offers a comprehensive database, UniProt, which contains variety of protein 
information besides sequences (UniProt 2015). NCBI offers several databases, each of 
which is independently served. The following list explains the currently active databases 
that store, annotate, organize and serve protein sequences. 
i. UniProtKB/Swiss-Prot (by EMBL) hosts proteins which were curated and 
reviewed manually. 
ii. UniProtKB/TrEMBL (by EMBL) contain proteins that are automatically 
annotated. 
iii. UniParc (UniProt Archive by EMBL) is a non-redundant database and each 
protein sequence (collected from different resources) is assigned to an ID.  
iv. UniRef (UniProt Reference Clusters by EMBL) contains sets of UniProtKB 
(including isoforms) and selected entries from UniParc. The sets are non-
redundant as homologous proteins are clustered together. The sets of 
UniRef100, UniRef90 and UniRef50 were defined based on the sequence 
identity (100%, 90% and 50% respectively) that is used to cluster similar 
sequences.  
v. GenPept (by NCBI) is collection of protein records which are automatically 
translated from coding sequences in the GenBank resource. 
vi. RefSeq (by NCBI) database contains non-redundant and curated set of 
proteins (Pruitt et al. 2012). A protein record is not repeated in this database 
for the same genome. It does include alternative gene products, isoforms.  
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vii. NCBI non-redundant (NR) database is the collection of protein sequences in 
which identical sequences are clustered together. Though the main resource is 
GenPept, it is not limited to it. The sequences are also collected from other 
resources such as RefSeq, Protein Data Bank (PDB), UniProtKB/Swiss-Prot 
etc. 
By definitions UniProtKB/TrEMBL and GenPept should be similar type of databases as 
they automatically annotate proteins from coding sequences. UniProtKB/Swiss-Prot and 
RefSeq databases are subsets of UniProtKB/TrEMBL and GenPept respectively. By the 
same logic, they can be considered equivalent, as their objective is to characterize 
proteins manually. UniParc and NCBI nr databases can be considered similar because 
they are collections of unique protein sequences. These two streams of protein sequence 
resources (maintained by EMBL-EBI and NCBI) share the majority of the sequences, 
however the content of the databases are not identical. Therefore, the results using the 
“equivalent” databases may not be the same.  
2.2 Comparative sequence analysis 
Duplication followed by polymorphisms and selection pressures are the main processes 
driving the evolution of genes - de novo inventions are more infrequent than alterations 
of existing coding regions (Hughes 1994). Because genes were derived from each other, 
homologous genes/proteins have similarities in terms of sequence. Therefore, a protein 
with unknown function can be compared to the existing ones in order to predict potential 
function, interaction partners and cellular localization. Comparative analysis of DNA and 
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protein sequences has been a successful branch of computational biology since the 
beginning of the genomics era.  
Nucleotide and amino acid sequences are composed of alphabets with the length of four 
and twenty respectively. One can expect that sequence comparison should not be 
different than text string comparison from the computational point of view. Although the 
string and sequence comparison algorithms are comparable, the parameters in molecular 
biology are different. First, there are indels in evolution, which can be short piece of 
sequence as well as long stretches. Second, the single point mutations should be taken 
into account carefully by considering about the likelihood of substitutions. Not all of the 
amino acid substitutions are equally tolerable. For this reason, there is always a guide in 
sequence comparison, called substitution matrix. These matrices include scores for each 
possible amino acid substitutions. The amino acids sharing physiochemical properties 
are more likely to replace each other. In benchmark alignments of homologous 
sequences, the statistics of each substitution establish the tendency patterns of amino 
acid replacements. Therefore, by guidance of the matrix, this kind of substitutions is 
favored. 
Sequences must be aligned in order to match the residues sharing common position in 
the ancestral sequence. Due to indels, sequences may not be aligned perfectly. Thus, 
indels are represented by gaps introduced in the alignment. In the alignment algorithms, 
a gap is introduced with a penalty cost to prevent false/artificial indels.  There are two 




2.2.1 Pairwise alignment 
Basically, the aim of pairwise alignment is to answer the question of “Are two proteins 
homologous?”. Although similarity is a good indicator of homology, it doesn’t necessarily 
prove it because similarity between two sequences may arise by random chance. Also, 
sequences may share only partial similarity due to gene duplication, fusion and deletion 
events. For this reason, there are methods developed to detect positional and general 
similarities. Thus, there are two types of pairwise alignment: (i) local and (ii) global 
alignments (Figure 2-1).  In global alignment the aim is to align entire length of 
sequences. On the other hand, local alignment focuses on subsequences that are most 
similar between two sequences. The aim of local alignment is to find the subsequences, 
which give the highest score (calculated from the substitution matrix) when aligned. 
Because introduced gaps cause penalties in alignment scoring, the number of gaps in 




A) Global and B) local alignments. 
Figure 2-1 Pairwise alignment types.  
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Pairwise comparison of n number of sequences with each other is computationally easier 
than building multiple sequence alignment of n sequences. Thus, pairwise alignment 
calculations are efficient and relatively fast in comparison to multiple sequence 
alignments. There are tree methods in this type of alignment: (i) Dot-matrix method; (ii) 
Dynamic programming and (iii) Word method (Rekepalli 2007). Dot-matrix method is 
efficient to reveal insertions, deletions and repeats. However, it is slow when analyzing 
large sequences.  Dynamic programming, itself, cannot identify insertions and deletions 
efficiently. “Word” (or k-tuple) remains as the most efficient, and thus preferred pairwise 
alignment method. By this approach, unnecessary calculations between irrelevant 
sequences are avoided. Although this method doesn’t result in the optimum alignment, it 
is fast and thus appropriate to search similar sequences in large databases. 
2.2.1.1 BLAST: The popular pairwise sequence comparator 
There have been several algorithms developed to perform pairwise alignments in order 
to calculate similarity score between pairs of genes/proteins, but most of them did not 
scale efficiently with the number of sequences to be searched. After BLAST algorithm 
was developed, most probably because of its speed, it became the most popular tool to 
retrieve similar sequences. It uses the Word method to align two sequences. BLAST 
algorithm has several subprograms to search different input types against different types 
of databases (Table 2-1). Because this dissertation focuses on proteins, this chapter 




Query Subject Program to Use 
Nucleotide Nucleotide blastn or tblastx 
Nucleotide Protein blastx 
Protein Nucleotide tblastn 
Protein Protein blastp 
 
The alignment scores are calculated through a substitution matrix of choice such as 
BLOSUM (Blocks Substitution Matrix) or PAM (Percent Accepted Mutation).  PAM is 
derived from evolutionary distances of proteins. The following number (i.e. 30 in PAM30 
matrix) indicates the allowed percentage of substitutions in 100 amino acid-length 
sequence. PAM250 matrix accepts multiple substitutions per site. Unlike PAM, BLOSUM 
is not designed based on evolutionary distances. Ungapped alignments of protein families 
(or domains) are considered as reference. The number followed by BLOSUM (such as 
62 for BLOSUM62 matrix) is the indicator of identity threshold when clustering sequence 
to build blocks. 
 A single matrix cannot be efficiently applied for every case as each BLAST query has its 
own evolutionary dynamics (Altschul 1991; Altschul 1993). By default, BLOSUM62 
(Figure 2-2) is utilized by BLAST, which has shown to be most efficient scoring matrix in 
identifying low similarities in general (Henikoff and Henikoff 1992). For short protein 
sequences, the scoring matrix should be more conservative for substitutions in order to 
eliminate false positives. Compared to BLOSUM, PAM matrices have higher mismatch 
penalties for amino acid substitutions, consequently they are more appropriate for short 
(less than 50 amino acids) length of queried sequences (Figure 2-2).  
Table 2-1 BLAST programs.  
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NCBI is the primary host for the BLAST algorithm. It enables users to “blast” their 
sequence of interest on a database of choice (such as RefSeq, NR, Swiss-prot etc.) and 
against a specified taxonomic level. Therefore, the database to search similar sequences 
can be manually set. Statistical significance of the hits (found similar sequences matched 
to query) is indicated by an important parameter called E-value. E-value depends on the 
database size and gives the number of hits to expect due to random chance only (Kerfeld 
and Scott 2011). Lower E-values means that the match is less likely to be false a positive. 
For instance, with E-value of 1 indicates one false positive “similar” sequence expected 
to be found by random chance in the given database. 
BLAST algorithm is heuristic and it aims to find similar sequences quickly without the 
concern of finding optimum alignments. Thus in principle, when two sequences are 
compared by BLAST, presence of another local alignment with higher score than the 
match is possible. Also, because it is a local alignment tool, it is not designed to provide 
high quality global alignments. For these reasons, though it is one of the fastest tools to 
find similar sequences on large databases, BLAST shouldn’t be used to infer distances 
between two proteins and it cannot replace the function of multiple sequence alignment 
tools. 
2.2.1.2 PSI-BLAST: To detect distant homology 
The problem of pairwise alignment is the fact that only obvious similarities can be 
detected. Subtle similarities may not be identified through pairwise comparison (Figure 
2-3). Two homologous sequences derived from a common ancestor could have diverged 
enough to loose amino acid identity. However, the physical-chemical composition of 




Both matrices have identical entropies. Copied from (Henikoff and Henikoff 1992). 
 
homologous sites with reduced alphabets. A functional unit of a protein have a profile 
which carries the characteristics of the represented unit. Remotely related and 
functionally equivalent proteins share alphabet characteristics (profile) to perform the 
same function. Thus, a profile can be used as a signature for detecting remote 
homologies.  
To overcome the sensitivity problem of pairwise comparison, PSI-BLAST (Position-
Specific Iterative Basic Local Alignment Search Tool) was developed. The algorithm is 
processed iteratively. First iteration is identical with the conventional BLAST procedure. 
A query sequence is blasted against a database. Before next iteration, significant BLAST  




Sequence 1 and Sequence 4 are distantly related with no sequence identity. It is not possible to 
identify the relationship by comparing these two sequences only. 
 
hits (under a specified e-value) are collected and aligned. From the alignment, a profile 
is generated. The profile includes observed amino acid counts for each position in the 
alignment. These counts are used to determine the likelihood of observing a certain amino 
acid at a certain position. This profile is called PSSM (Position-specific scoring matrix). 
PSSMs contain the conservation pattern of the sequence they represent. In the second 
iteration, the newly generated PSSM is used as query. Compared to pairwise alignment, 
PSSM is more sensitive to find similar hits as it contains information from not a single 
sequence but multiple sequences. After collecting the results, new significant hits are 
added to the alignment, which is used to generate a newer PSSM. For each iteration, 
PSSM is recalculated with the newly selected sequences and queried against the 
selected database. After each iteration new hits can be found or new hits may not be 
Figure 2-3 The problem of pairwise comparison in detecting remote homology.  
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found after some point. Thus, the process is iterated until the point of satisfaction with the 
results, an arbitrary iteration number, or the point that no new sequences can be captured. 
It is important to note that PSI-BLAST algorithm, as other BLAST tools, is heuristic i.e. it 
doesn’t guarantee to yield the optimal solutions.  
Like other BLAST tools, PSI-BLAST is also available at NCBI webserver. Additionally, the 
graphical user interface is convenient to apply PSI-BLAST. In every iteration, users are 
given an option of which hits to include and exclude in the computation of the following 
PSSM. In PSI-BLAST, hits are not guaranteed to be sorted from most to least similar. For 
this reason human intervention is important. In this case deciding on what to include is a 
challenge. Statistical significance is an important criterion to be careful about. When 
manually performing PSI-BLAST on NCBI server, if a hit is at the border of statistical 
significance, there are consequences of including and excluding the hit depending on the 
truth of match. If the hit is false positive, inclusion of an irrelevant sequence may make 
the next PSSM more diverged, which would result in more false positives at the next 
round. If the hit is true positive, but a diverged one, excluding that sequence in PSSM 
may end the iteration at that point and more distantly related proteins may never be found. 
2.2.2 Multiple Sequence Alignment 
Multiple sequence alignments (MSAs) are built to compare three or more DNA or protein 
sequences with each other.  Usually, sequences that are related to each other with a 
common ancestor are aligned to reveal common patterns as homologous sites. Moreover, 
MSAs are prerequisites for most of phylogenetic analyses. The aim of MSA is to align 
homologous residues, such as amino acids which used to have the same common 
ancestor. Thus, columns in the alignment should ideally be homologous residues in each 
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position. The length of sequences can be different in homologous sequences due to 
insertions and deletions. For this reason gaps are introduced and represented with 
hyphens.  
MSAs can be built manually or automatically. Because manually aligning sequences is 
tedious especially for large data, computational algorithms were developed to perform 
this task. Automatic MSA building is an extensive research topic in the field of 
computational biology. Few popular MSA tools are: CLUSTAL W, T-Coffee, MUSCLE and 
MAFFT. 
As homologous sequences are derived from a single ancestor, every residue in a 
sequence had an ancestor residue (except for recent insertions). Although in theory there 
should be a single correct MSA having only homologous residues aligned, in practice this 
is not possible yet. Computational algorithms generate more than one MSAs. The “best” 
MSA determined by specific criteria is selected to be the optimum one. However, in most 
cases, the optimum MSA does not identically reflect the true alignment. Thus, the 
achieved MSA is an approximation and it usually contains mistakes. Manual refinements 
should be applied on automatically generated MSA.  
Substitution matrix is the most important criterion in building MSAs. In protein sequence 
alignment, the substitution matrices are based on the observation of current substitutions. 
Usually, amino acids sharing one or more physical or chemical property are more likely 
to substitute each other. For instance, S and T are often replaceable because they are 
small and polar. Additionally, D and E (negatively charged and acidic); H, K and R 
(positively charged); F, I, L, M, V (hydrophobic); F, Y (aromatic) are often interchangeable 
when only their physiochemical characteristic is conserved at a certain position. Cysteine 
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(C) on the other hand is not replaceable with any amino acid when it builds a disulfide 
bond which is crucial for the protein structure. In DNA alignment, application of a 
substitution matrix is not possible because of the small size of the nucleotide alphabet. 
For nucleotide alignment there is ~1/4 random chance of having an identical match. 
Therefore, in DNA alignment only identity is used as the substitution matrix: Adenine (A) 
can be favorably matched only with A. For this reason, nucleotide alignments are often 
ambiguous and result in more mistakes compared to protein sequence alignments. 
Therefore, if possible, instead of aligning DNA of a coding region, building MSA on amino 
acid sequence yields more reliable results. If nucleotide sequence of a coding region is 
needed for the analysis, building DNA alignment generated from protein alignment 
(reverse translation) can be used. 
2.3 Phylogenetics and Taxonomy 
In biology, it is important to know about the historical relationships between species or 
inherited biomolecules. This can be achieved by DNA and/or protein comparison or 
manually curated classification. This chapter introduces basic approaches of hierarchical 
classification of organisms and biological sequences. 
2.3.1 Phylogenetics 
Phylogenetics is the study of the evolutionary history of organisms (or their hereditary 
components) achieved via genetic material. Typically, a phylogenetic tree is inferred from 
a sequence alignment. Alignments ideally contain only homologous sequences and 
residues in an alignment column share a common ancestor. A phylogenetic tree should 
represent the evolutionary history of subjects while explaining the alignment it is derived 
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from. There is a single correct tree, but it is not easy to achieve. Calculations of the 
likelihoods of all possible tree topologies are computationally impossible with the current 
hardware for more than tens of sequences. So, the aim of algorithms is to pick the best 
tree among calculated ones. 
2.3.1.1 Methods 
There are four major methods to build phylogenetic trees: (i) distance matrix; (ii) maximum 
parsimony; (iii) maximum likelihood and (iv) Bayesian. 
The distance method depends on relative evolutionary distances between each pair of 
sequences to be compared. The distance can be achieved through pairwise comparison 
by which a genetic distance matrix is established (Felsenstein 1988). Pairwise 
comparison results in an underestimated genetic distance as they count each 
polymorphism as a single mutational event, which may actually be caused by multiple 
events (Salemi and Vandamme 2003). Underestimated dissimilarity score can be 
converted to an evolutionary distance by an adjustment formula (Jukes and Cantor 1969). 
Then, tree topology is inferred from estimated distances. There are a few types of tree-
building approaches based on evolutionary distances such as the clustering approach 
and the neighbor-joining method. 
UPGMA (Unweighted Pair Group Method with Arithmetic Mean) is one of the clustering 
methods that provides a hierarchically clustered tree. This algorithm assumes that all 
sequences to be compared are at an equal distance from the root. Therefore, all tips of 
the individual branches are aligned (Figure 2-4). In reality, this is hardly the case. Two 
biological species are rarely at the identical distance from their closest common ancestor, 
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as their evolutionary rates are likely to be different. For this reason UPGMA is rarely used 




Left panel shows a cladogram which UPGMA results in. Right panel shows a phylogram. 
 
Neighbour-joining (NJ) is another distance-based method that is computationally efficient. 
The algorithm clusters the two closest taxa and considers the cluster as a single node to 
compare with others and additively constructs the tree. In order to achieve the correct 
phylogenetic tree with NJ approach, distance matrix must be statistically consistent. In 
other words, the additive algorithm should progress with matching distances in the matrix. 
Because distance matrix generating algorithms are approximations, the true distance 
Figure 2-4 Cladogram vs phylogram.  
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table cannot be produced easily. Thus, the NJ approach may also fail to yield the correct 
tree. It is preferable over more accurate non-distance-based tree inferring methods due 
to its efficacy in computing. A tree from thousands of sequences can be built with NJ in a 
short time on a single node. It is also preferable over the UPGMA approach because it 
doesn’t assume that all sequences have evolved at the same rate, thus it results in non-
equal branch lengths from the root.   
Maximum parsimony approaches assume a minimum evolutionary event number to 
achieve the observed data. It assigns common ancestors to each node in a way that it 
favors the minimum substitution number. Although the logic behind the method is 
reasonable for morphological properties, for DNA/protein sequences, it is not well suited. 
In sequence alignments there is more than one way to achieve minimum evolution, which 
may result in multiple optimal trees. With morphological data, which contains more 
complex structures that are less likely to evolve independently compared to sequence 
residues, maximum parsimony performs well.  
Maximum likelihood (ML) is a statistically well-understood method to estimate parameters 
of an evolutionary model that explains the evolutionary process in which the observed 
data went through. In phylogenetics, this approach can be used to evaluate the pattern 
of branching by considering probabilities explaining the observation under a given model. 
ML is a powerful tree-inferring method as it provides biologically meaningful trees 
compared to parsimony and distance-based approaches. However, it is computationally 
intense. Because searching every possible tree may not be plausible, a heuristic method 
is usually applied. Even the heuristic approach doesn’t enable applying ML on large data 
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sets containing over thousand sequences due to computational constraints, unless there 
is a chance of using a supercomputer. 
Bayesian inference is another method to generate trees from sequence alignments. It is 
similar to ML because it also uses a likelihood function and results in the probability 
distribution of possible trees. However, the difference of this method is that it uses prior 
knowledge on the data (prior probability) to calculate posterior probability. As a heuristic 
method it doesn’t guarantee the best tree. However, it is used as widely as the ML 
method. One main disadvantage of this method is the lack of speed given the nature of 
the algorithm. For small sets of sequences Bayesian inference works well. 
2.3.1.2 Which One to Use: Protein or DNA Sequence? 
DNA is the source of information that is needed to synthesize proteins, whereas proteins 
are the fundamental functional elements in molecular biochemistry, which are subject to 
natural selection rather than protein coding DNA regions. Coding DNA can be modified 
as long as protein function and expression are maintained. For reasons explained below, 
using protein sequences in phylogenetic analysis is more appropriate to obtain trees 
closer to the “true” tree. 
1) Multiple codons one amino-acid 
As discussed in the introduction same amino-acid can be encoded by multiple codons. 
For this reason, any codon producing the required amino acid will not be under an 





2) Codon usage bias 
Organisms may have different preferences for certain codons which encode for the same 
amino acid. Thus, comparing DNA sequences from different organisms may reflect an 
artificial change in nucleotides which have no effect at the protein level. 
3) “Almost” universal genetic code 
Genetic code is general and applies to nearly all organisms with exceptions. Unusual 
genetic codes were reported in lower eukaryotes (Horowitz and Gorovsky 1985; Salemi 
and Vandamme 2003). Non-identical (or even non-equivalent) codons may result in same 
amino acid sequences.  
4) Higher noise in DNA 
In a DNA sequence there are only four letters and at any position of the alignment there 
is 25% chance of matching nucleotides randomly. Therefore, the probability aligning non-
homologous residues is much higher in DNA compared to proteins which would have 
~5% probability of “by-chance” misalignment. Therefore, by using proteins, it becomes 
more likely to align homologous residues (the amino acids that share a common ancestor 
at the same position). 
5) Non-coding regions within a gene 
Genes include regions called regulatory sequences which are not transcribed. In 
eukaryotes, there are introns which are removed at pre-mRNA level after transcription. In 
addition, there are untranslated mRNA regions. Therefore, in order to infer meaningful 
phylogenetic trees these regions should be removed from the DNA alignment, as they 
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can be highly divergent and cause substantial unnecessary noise in the MSA. A high-
quality gene alignment at DNA level can be performed using only coding regions.  
On the other hand, there are minor drawbacks of using protein sequence. First, 
positive/negative selection cannot be quantitatively identified using only protein 
sequences. Second, non-coding sequences may contain conserved information and they 
are only accessible at the DNA level. And finally, in eukaryotes, alternatively spliced 
proteins result in variations of in the products of the same gene. Thus, even if the protein 
sequences are originated from the same gene, they cannot be aligned well at splice site 
regions. The last drawback is addressed in chapter 5. 
2.3.1.3 Reading phylogenetic trees 
A connected sets of organisms in trees is called a taxon (plr. taxa). Each tip (often called 
leaf) represents an organism (or gene/protein) while each node represents the common 
ancestor of the descendants (Figure 2-5). Phylogenetic trees reflect not only clusters of 
similar taxa but also evolutionary relationship between them, which is the point of 
difference between phylograms and cladograms. Evolutionary trees show how ancestors 
are related with their descendants quantitatively. In a vertically aligned tree, the distance 
between two taxa is measured by the total vertical branch length (Figure 2-5). A clade is 
a set of organisms that share an ancestor whose all descendants are in the set (Figure 
2-5). Clades are composed of minimum two organisms. Small clades can be nested in 








Taxonomic trees reflect hierarchically categorized organisms and aim to represent 
evolutionary classification. There are several different attempts on building taxonomic 
classification. Most of these databases are specialized in a certain clade of organisms 
such as bacteria, plants etc. NCBI offers the most comprehensive taxonomy database 
with the attempt of including all organisms from each domain of life (including viruses and 
viroids). This database is carefully built and maintained by considering not only 
DNA/protein similarities between organisms, but also consensus literature in the 
classification. Ranking categories start from root (which includes every organism with no 
exception) to subspecies and every kind of other rankings between them. Each species 




and classification node is given a “taxid” which is a unique identifier. Every node including 
species can be traced back to the root with the lineage information. One drawback of the 
classification is that ranking levels from root to species are not standard. One organism 
may have only 8 levels described, whereas others may have 16. So, not every organism 
has the same hierarchical levels. 
Resolving ancestral relationships in early eukaryotic domain of life remains a challenge 
(Burki et al. 2007). There is no consensus of how deep eukaryotic groups are connected 
to each other (Hampl et al. 2009). Although their evolutionary relationships couldn’t be 
established, there are 5-6 eukaryotic supergroups known to be diverged at early stage of 
eukaryotic evolution. These supergroups are: Unikonta (Opisthokonts and Amoebozoa), 
Chromalveolata, Plantae, Excavata and Rhizaria (Koonin 2010). Because their 
hierarchical relationships are arguable, eukaryotic supergroups are not used in taxonomic 
database. However, supergroup assignment to genomes would be useful to detect the 
genes that are common in all of them, which is an indicator of the presence of the genes 
in the last eukaryotic common ancestor (Koonin 2010). 
Generally, taxonomic databases provide a good overview of which organisms are similar 
to each other, however it has low resolution within clades. For instance, a question of 
which species within a genus are more similar to each other cannot be answered unless 




2.4 Protein Domains 
Amino acids are the building blocks of proteins. Linked amino acids (polypeptide chains) 
fold and give rise to three dimensional protein structures. Proteins are composed of one 
or more functional and structural units, called domains, which evolve and function 
independently from the rest of the protein. Domain sizes are limited. With 100 amino acids 
in average, majority of domains are shorter than 200 and longer than 40 amino acids 
(Islam et al. 1995; Jones et al. 1998; Wheelan et al. 2000).  
As structural units, domains are not fully conserved sequence-wise. A motif is found in a 
domain, a set of multiple amino-acid residues, which is probably the most critical 
sequence pattern for the biological function of the protein. Because they are actively 
involved in the function (such as catalytic activity, binding, protein-protein interaction etc.) 
motifs are highly conserved and cannot be mutated without a cost in fitness. Residues of 
motifs are structurally in close proximity with each other and most of them are closer to 
each other at the sequence level. Unlike domains, motifs cannot be classified as structural 
units. A fold on the other hand, represents a domain or a smaller unit of a domain from 
the structural point of view only. Folds are composed of multiple secondary structural 
elements. A domain is composed of a single or more folds. 
Single domain proteins (SDPs) are more often found in the early stages of life where 
MDPs are considered as more recent as they are derived from SDPs  (Di Roberto and 
Peisajovich 2014). Evolution of new protein functions occurs through combining and 
rearranging domains. Organismal complexity positively correlates with the abundance of 
multi-domain proteins (MDPs) (Di Roberto and Peisajovich 2014). MDPs are produced 
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by evolutionary mechanisms such as duplication, fusion, disassociation and divergence 
(Kummerfeld and Teichmann 2005). Though it is possible to invent a domain from 
structurally disordered sequences, this mechanism remains minority among others 
(Moore and Bornberg-Bauer 2012; Di Roberto and Peisajovich 2014).  
In functional networks, domains play important roles because of their characteristics. 
Firstly, a domain is an independently-evolvable unit, thus it can exist in various domain 
organizations. In different compositions, sub-functionalization may occur which results in 
function divergence of the entire protein. Secondly, many domain functions are 
extensively regulated. Besides getting turned on/off, the activities vary based on 
molecule-binding and post-translational modifications. Due to their flexibility in adapting 
to proper function, domains are highly dynamic in terms of evolution. Useful domains 
adopted through either vertical or horizontal evolution are kept because of advantage they 
contributed in the fitness of organisms. 
Domain fusion is one of the major mechanisms in generating a new function. Interacting 
domains on different poly-peptide chains can be fused to act together. Fusion saves cost 
in protein synthesis and molecular transport, and thus fusion of interacting SDPs is 
favored in the evolution. Therefore, domains in MDP, if they exist as single proteins, it is 
very likely that they do interact with each other. This is one way to deduce protein-protein 
interactions in silico. However, not all domains are evenly involved in various domain 
combinations, and some of them even don’t easily fuse with another one as they are 
highly conservative in domain architecture preference. These domains are more 
conserved than the ones freely involved in various domain architectures.  
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To conclude, protein function evolution and new protein invention heavily depend on the 
dynamic nature of domain evolution. For this simple reason, understanding domain 
evolution contributes to understanding protein evolution and thus function. 
2.4.1 Domain search methods 
Pairwise sequence comparison is not sensitive in identifying homology (Figure 2-3). 
Homologous sequences share common characteristics, such as conserved residues, 
motifs, secondary structure patterns etc. These characteristics are reflected on the 
sequences and easily detectable through MSAs. MSA can be summarized by profiles that 
represent a family of related (homologous) sequences by containing their conserved, and 
thus important characteristics. Profiles are used frequently to detect homology more 
sensitively.  
One type of profiles is amino-acid frequency matrix, PSSM, which is used in PSI-BLAST 
algorithm. A domain alignment is converted into a PSSM which can be queried to search 
for new sequences belonging to the domain family represented by the given matrix. A 
sequence can also be queried against PSSMs to scan which domains are present in the 
protein. RPS-BLAST (Reverse PSI-BLAST) is a tool enabling search of sequences 
against a PSSM database. Matrices contain frequencies of amino acids in each position 
of proteins. The complete information of an MSA cannot be represented by a score matrix. 
PSSM profiles are strict about insertion and deletions which reduces applicability for 
length wise diverging domains. Because of these limitation in substitution matrix-based 
profiles, probabilistic profiles were developed.  
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The most popular of these profiles uses a statistical method called Hidden Markov Model 
(HMM). HMMs take into account the likelihood of every possible transition state 
categorized as match, insertion and deletion. Thus, HMMs contain information of the 
probabilities of state changes as well as the frequencies of each residue in an alignment 
column. Each position in an HMM has two types of probability: transition and emission. 
Transition probability is simply the likelihood of transitions between ‘match’, ‘insertion’ and 
‘deletion’ states. Emission probability is the likelihood of observing an amino acid or an 
insertion at each position. HMMs are more complicated than PSSMs, as they store more 
information and offer more sensitive domain identification. Sequence of interest can be 
compared with HMM of a pre-compiled domain/protein family in order to question the 
relationship. This is a widely used approach to identify protein domains. HMMER3 is a 
well-known package of HMM profile-related tools (Mistry et al. 2013). HMMscan tool 
allows searching sequences against a profile database whereas HMMsearch is used to 
search a certain profile against a sequence database. HMMbuild generates HMM out of 
a given MSA.  
HMMs substantially contributed in protein/domain classification and identification. 
However, in the investigation of distant homology, the sensitivity of the HMM-sequence 
comparison still remains under the desired level. A more sensitive approach was 
developed, which is HMM-HMM comparison. First, a sequence of interest is searched in 
a sequence database to find closely related sequences using pairwise similarity searches. 
Significant hits are collected and aligned. The built MSA is then converted to an HMM 
profile. Next the HMM profile is queried against the same sequence database. Because 
an HMM is used now, the search is likely to result in newer hits. The new significant hits 
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are also added to the alignment, which is then converted to a second HMM and the 
process is repeated several times (Figure 2-6). The final HMM profile is then compared 
with a collection of HMMs. The HMM-HMM comparison (Figure 2-7) helps in detection of 
distant homologies. HHsearch is a popular tool that is often used for HMM-HMM 
comparisons. 
2.4.2 Protein/domain profile databases 
Domain profiles are annotated and organized in different forms in several databases. The 
most popular domain profile database is Pfam (Protein Families) (Finn et al. 2014). Pfam 
contains MSAs and derived HMM profiles for domains. HMMs in Pfam are built using 
HMMER3 (Mistry et al. 2013). Pfam-A is the primary collection containing manually 
annotated protein/domain families. Pfam-B is another resource for other families which 
are built automatically from protein/domain clusters retrieved from ADDA (Automatic 
Domain Decomposition Algorithm) (Heger et al. 2005) database. These protein clusters 
are not manually checked and thus not annotated. Pfam-B domains are generated from 
protein/domain clusters which don’t overlap with any current Pfam-A models. Therefore, 
the aim of Pfam-B is to cover “orphan” sequences, however they don’t give any biological 
insight other than the conservation characteristic of the region.  
TIGRFAM is another HMM-based database as it also uses HMMER3 to build models 
(Haft et al. 2013). Unlike Pfam, it is not domain-oriented. TIGRFAM includes profiles of 
full-length proteins. Therefore, both SDPs and MDPs are represented by single profiles. 
TIGRFAM is useful to determine protein families but it is not primarily used to assign 
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SMART (Simple Modular Architecture Research Tool) database is another domain 
collection composed of HMM profiles (Letunic et al. 2015). The most important feature of 
the database, which makes it different than other resources, is that the domains are 
manually and carefully annotated, and external links to variety of databases are provided.   
The latest release (version 7) of the database contains only 1204 distinct models.  
PIRSF is a database of protein classification that is manually curated (Nikolskaya et al. 
2006). Only proteins sharing full-length similarity and having same domain architectures 
are clustered together. However, as other manually curated databases, it is not 
comprehensive. Moreover, length-wise diverged protein sequences are not clustered 
together which causes a drawback of losing homology between them. 
Figure 2-7 A representative scheme of HMM-HMM comparison.  
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COG (Cluster of Orthologous Groups) database is semi-automatically generated and 
includes clusters of protein and domains which are likely to be orthologous (Galperin et 
al. 2015). Because the clusters are built automatically, they also include paralogs. The 
algorithm of COG is based on pairwise sequence comparison in the context of individual 
genomes. It is different than a regular domain database as only orthologous domains are 
clustered together. So same domain can be classified in multiple COGs if it is involved in 
various domain architectures.  
Another frequently used database is CDD (Conserved Domain Database) (Marchler-
Bauer et al. 2015). Unlike Pfam, TIGRFAM and SMART it is a database of PSSMs. 
PSSMs are built from manually curated MSAs and sequences are compared with profiles 
via RPS-BLAST. Domain boundaries are primarily determined by available protein 
structures, if one exists. CDD also includes PSSM profiles built from MSAs which were 
retrieved from external databases such as Pfam, SMART, KOG, COG and TIGRFAM. 
SCOP2 is an upgraded version of SCOP (Structural Classification of Proteins) database. 
The database is a collection of hierarchically clustered domains. The classification 
principle is structure-oriented. The hierarchical classification levels are as the following: 
 Structural Class: All alpha 
 Fold: Globin-like 
 Superfamiliy: alpha-helical ferredoxin 
 Family: pyrimidine dehydrogenase N-terminal domain-like 
 Protein:  Dihydropyrimidine dehydrogenase, DPYD 
SCOP2 also contains crosslinks on relationships between proteins in terms of evolution 
and structure (Andreeva et al. 2015). The database is manually curated, consequently 
reliable, however not comprehensive. SUPERFAMILY is an HMM-based database built 
on the SCOP domains at the superfamily level (Gough and Chothia 2002). 
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CATH is another structure-oriented collection of hierarchically classified domains (Sillitoe 
et al. 2015). It is semi-automatically maintained by using entries from PDB (Berman et al. 
2000). CATH is an abbreviation representing four levels of classification: (i) Class 
(equivalent to SCOP Structural class); (ii) Architecture (equivalent to SCOP fold); (iii) 
Topology; (iv) Homologous superfamily (equivalent to SCOP superfamily). The database 
is built on solved structures. Gene3D is a collection of CATH classifications applied to 
protein sequences by revealing similarities between solved structures and other 
sequences whose structures have not been solved (Lees et al. 2014).  
SeqDepot is a comprehensive collection of various databases on a non-redundant set of 
protein sequences and their associated components (Ulrich and Zhulin 2014) . The 
motivation behind the database is to avoid unnecessary recalculations on predicting 
protein components for identical sequences. Each sequence in the database is 
represented by an id (20 characters), which is used to retrieve pre-computed sequence 
features such as hits from 18 resources including Pfam, TIGRFAM and SUPERFAMILY. 
2.4.3 Web-servers for domain searching 
Pfam website enables domain searching by HMMER3. It also includes a large repertoire 
of pre-computed domain architectures on UniprotKB sequences. Pre-computed domain 
architectures can be queried by entering desired presence and/or absences of domains. 
Phyletic distribution of single domain presence is also offered. However, genomic 
absences of domains are not shown. 
In Pfam, related domain families are clustered together with profile-profile comparisons 
such as HHsearch (Soding 2005) and SCOOP (Bateman and Finn 2007). Also the fact 
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that a same region of a sequence has significant hits for more than two Pfam profiles is 
considered as an indicator of related profiles, thus they are categorized as candidates to 
be clustered. These clusters are termed clans in the database.  Though domains which 
are members of the same clan are highly likely to share a common ancestor, the 
homology is not guaranteed.  
HMMER web server also allows domain prediction through HMMscan (Finn et al. 2015). 
Unlike Pfam it doesn’t store pre-computed domain architectures. It also allows 
HMMsearch by querying an MSA. MSA is converted to an HMM automatically with 
HMMbuild and generated HMM is searched on the database of choice such as Uniprot, 
SwissProt and PDB. 
CD-Search webserver allows querying sequences against CDD (or other compiled PSSM 
libraries) which is a collection of pre-calculated PSSMs (Marchler-Bauer and Bryant 
2004). The search is performed by RPS-BLAST. The web server also enables querying 
similar domain organizations through CDART (Conserved Domain Architecture Retrieval 
Tool) (Geer et al. 2002).  
SMART is another web resource for searching a sequence of interest on its own 
database. The most important feature of the SMART website is that it allows querying 
domain composition and organization (Letunic et al. 2015). By this feature a user is 
enabled to search for other proteins that have the same composition of the user’s input. 
Domain organization search allows finding proteins having only the domains in the same 
order with the input. Taxonomic distribution of the hits (only presence) is also offered.  
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HHpred is a platform enabling more sensitive domain investigation (Hildebrand et al. 
2009). The main goal of the tool is to utilize HMM-HMM comparison to infer remote 
homologies. The user enters a single input which is iteratively searched against Uniprot 
or NR database to find similar sequences. This search is performed by either PSI-BLAST 
or HHblits (Remmert et al. 2012) algorithms, by generating a profile after the first run, 
followed by the same procedure several times until a pre-determined iteration number is 
reached. At the end of the iterative sequence search, sequences found to be related are 
aligned and an HMM is built out of MSA. The generated HMM is queried against a 
collection of HMMs via HHsearch algorithm. Libraries of HMMs are built from databases 
retrieved from several resources such as Pfam, PDB, SCOP, CDD, Panther, PIRSF, 
COG, CATH and SUPERFAMILY. The web server also offers an option to limit the search 
with one of the several representative genomes. By default, HHpred also uses a 
contribution of secondary structure information when detecting similarity between profiles. 
Secondary structure information can be retrieved from either a computational prediction 
or a structure database (such as PDB).  
HHpred web-server allows a single query at a time. If the query is a single sequence (not 
MSA), similar sequences are searched via HHblits by default. For multi-domain proteins 
similarity search is biased towards finding the sequences with a similar domain 
architecture (Hildebrand et al. 2009). Moreover, the profile built at every step of iterative 
process will represent the domain architecture of the initial query. The biased domain 
architecture will be specific to find domains which are similar to ones found in the same 
domain organization. More diverged domain sequences, especially the ones that are 
found in different domain organizations, are less likely to be identified. Therefore, in this 
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case, the results do not reflect the true sequence diversity of the protein family. This 
causes a narrower spectrum of the HMM profile and, consequently leads to lower 
sensitivity than theoretical limit (Figure 2-8). If possible generating profiles out of 
individual domains would be more sensitive to find more distantly related sequences.  
It is worth to note that though there are databases containing pre-calculated HMM-
sequence comparison results, there is no such database for HMM-HMM comparisons. 
Because HMM-HMM comparison is computationally expensive and there is no standard 
procedure to build first HMM to compare against a collection. With the current hardware 
and software capabilities, HMM-HMM results can only be achieved through via “on the 
fly” computations.   
2.4.4 Other protein components  
Low-complexity regions (LCRs) are subsequences composed of biased amino acid 
composition with a little degree of diversity (DePristo et al. 2006; Coletta et al. 2010). Most 
of them are sequences composed of one or few different amino acids, or in other words, 
it utilizes only a limited subset of the amino acids alphabet. LCRs are usually non-
conserved, irregularly spaced and repeated. About 12% of Uniprot amino acids are found 
to be within LCRs (UniProt 2008). These sequences become non-globular/disordered 
structures when translated. In sequence similarity searches including profile-sequence 
comparisons, LCRs cause false positive matches. Therefore, hits on the LCR part of a 
sequence should be taken into account cautiously. SEG is an algorithm used to predict 










Coiled coils are structural units that are formed by anti-parallel two or three alpha helices. 
The amino-acid composition of these units shows a predictable pattern which is a 
combination of hydrophobic and hydrophilic amino acids. From sequence information 
only, coiled-coils can be easily predicted. COILS is an algorithm developed to predict 
these structural folds (Lupas et al. 1991).  
Proteins can be cytoplasmic or membrane associated. Membrane-bound proteins have 
at least one region anchored within membrane. Transmembrane regions are composed 
of mostly hydrophobic residues. Though secondary structure of these regions are usually 
alpha helices, there are membrane proteins with beta barrel structures. Membrane-bound 
alpha helices can be computationally predicted with HMM approach. TMHMM is a popular 
tool to predict transmembrane alpha helices (Sonnhammer et al. 1998). 
Signal peptides are short N-terminus regions of some proteins which are recognized by 
transporter proteins to transfer proteins to the subcellular location where they function. 
After translocation, signal peptidase cleaves this sequence. These regions are composed 
of hydrophobic residues, which in turn form an alpha-helix type structure. For this reason, 
signal peptides can be wrongly predicted as transmembrane helices. PHOBIUS is an 
algorithm to distinguish between signal peptides and transmembrane helices (Kall et al. 
2007). 
2.4.5 Domain coverage 
Proteins can be defined and annotated based on the domain content. However, there are 
proteins that have not been found to be composed of any domain. Moreover, in multi-
domain proteins, identifying only a single domain will not solve the problem of 
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understanding the function of the entire protein. The orphan sequences have been 
referred as “dark matter” of protein universe (Rekapalli et al. 2012). Four potential reasons 
causing this dark matter of the proteins have been established: (i) errors in sequencing 
DNA, which would cause meaningless protein sequences and no similar sequences can 
be found; (ii) non-globular structures that are basically non-conserved disordered parts of 
proteins; (iii) inability to identify domains due to too diverged sequences by the course of 
evolution, which is a computational limitation; (iv) an encountered novel domain, which 
cannot be identified because of no similarity with the existing sequences (Levitt 2009).  
When inter-domain regions are subtracted orphan sequence ratio in protein universe was 
found to be ~40% in 2012.  The relative size of uncovered amino acid sequences is 
shrinking every year. From April 2009 to December 2011, the Pfam coverage increased 
3.4%. However, if the trend of domain coverage remains same, it will take more than 20 
years to cover proteins in terms of domains. This fact shows a necessity of applying more 
sensitive domain search algorithms. 
2.5 Human Genome and Genetic Diseases 
2.5.1 Human Genome 
Twenty years ago, an accurate estimate on the number of protein-coding genes in human 
genome couldn’t be made. Though in 1960s 2,000,000 genes were estimated, in 1970s 
the upper limit for this count was determined as 40,000 (Cristianini and Hahn 2006). 
Recent work, although not precisely, shows that the human genome contains ~19,000 
protein-coding genes which comprise only 1% of the human genome (Ezkurdia et al. 
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2014; Flicek et al. 2014). Overestimates on gene count were likely to be caused by the 
observation of the unique protein counts prior to the discovery of alternative splicing.   
Humans and mice share majority of their genes with 85% average sequence identity in 
coding regions and their genomes are comparably similar in terms of content and 
sequence. Most of mice genes show noticeable phenotypes when knocked out and ~30% 
of them cause prenatal fatality. Therefore, each human gene is also suggested to be 
critical in survival. However, impacts of 52% of human genes have not been determined 
yet (Chong et al. 2015). Clearly, there is still a lot to be discovered on human genes, and 
thus health. 
2.5.2 Variants 
DNA polymorphism is a variation in nucleotide sequence that is common in population. 
An arbitrary cutoff percentage to categorize a DNA variation as polymorphism is 1%. It 
means that when a variation is observed in more than 1% of the population it is called 
polymorphism. DNA polymorphism and mutation are often misused interchangeably. 
Although every polymorphism can be defined as a mutation, not every mutation is 
polymorphism. Novel mutations that are population independent should not be called 
polymorphism. Most polymorphisms are benign. If they were damaging then they would 
have a fitness cost, which would have resulted in a reduced allele frequency. However, 
in biology there are many examples of DNA polymorphisms that are damaging at certain 
conditions. Also, combination of polymorphisms can determine the phenotype in health 
and disease. The most common type of polymorphism is a Single Nucleotide 
Polymorphism (SNP). SNPs can be within non-coding as well as coding DNA regions. 
Coding SNP types are basically categorized as: (i) Non-synonymous (ii) Synonymous and 
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(iii) Nonsense. Non-coding SNPs can affect transcription, especially if they are in 
functionally important regions such as the promoter, enhancer and silencer.   
2.5.3 Sequencing Human Genes 
Current sequencing technologies aim to be cheap, fast and high throughput. Since 2005, 
high throughput parallel sequencing approach is called Next Generation Sequencing 
(NGS). Today, NGS platforms can sequence a human genome within a day with a cost 
of a few thousand dollars.  
2.5.3.1 Whole Genome Sequencing (WGS) 
The process of deciphering the entire DNA code of an organism including mitochondria 
(or chloroplast in plants) is called whole genome sequencing (WGS). WGS has an 
important advantage as it provides information about not only genes but also any other 
DNA region. Thus, for complicated diseases caused by multiple coding and non-coding 
regions, WGS is the most appropriate choice due its comprehensive scan. However, it is 
expensive compared to the other specialized sequencing approaches. For testing 
specifically certain genotypes, WGS would be a waste of money and time. High coverage 
in sequencing is obtained with an extra cost. Because WGS is already expensive, 
coverage levels are kept at minimum levels in order not to increase the cost. The low 
coverage results in low confidence. 
Human WGS results contain 6 billion (2 sets of chromosomes X 3 billion bases) 
nucleotides of information, in principle. Today, the analysis of the generated data is more 
challenging than sequencing. Although there is a number of robust algorithms available 
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for processing the raw data, manual intervention is considered as a must to deduce 
biological meanings.  
2.5.3.2 Whole Exome Sequencing (WES) 
The entire set of exons in the genome is called exome. Whole exome sequencing focuses 
on the exome and ignores other DNA regions. Because many known genetic diseases 
are associated with coding regions, most clinicians are interested only in exons. In 
addition, because only ~1% of the human genome is composed of exons, WES is 100 
times cheaper than WGS. It means that, 100 times more samples or coverage can be 
sequenced or achieved with the same cost. Like replication that DNA polymerases 
perform in cells, sequencing in laboratories is erroneous. The low cost of WES enables 
high coverage in DNA sequencing, which provides confidence in sequence analysis. 
2.5.3.3 Targeted Sequencing 
WGS and WES are usually used to identify the comprehensive list of variants, when a 
clinician suspects about a genetic case which has not been associated with a gene yet. 
However, in most cases DNA tests are performed to check if a certain gene/protein 
contains a mutation. In these cases only that part of the genome is targeted and 
sequenced. This approach is highly practical and preferable in terms of money, time and 
confidence.  
2.5.4 Mendelian Diseases 
A better understanding of diseases was probably the most encouraging motivation of the 
human genome project. Before the project started, the community expected to cure many 
diseases by understanding the causes with deciphered DNA code. However, sequenced 
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human genome came with many unknowns and as of today, the causes of many genetic 
disorders are still unidentified. There are two types of genetic disorders classified based 
on their mechanism of action: Mendelian and complex disorders. Mendelian traits are 
consequences of single gene variations which can cause disorders such as sickle-cell 
disease and cystic fibrosis. The inheritance pattern of Mendelian traits is simple and 
traceable. In complex disorders such as diabetes and cardiovascular diseases, there are 
more than one gene involved. For multi-genic disorders it is challenging to understand 
the contribution of each gene involved in the disease. The primary aim of many 
researchers was to understand the simpler of the two types, Mendelian disorders. 
Mendelian traits are caused by loss of function, activity change, mislocalization of 
proteins. About 8% of people are diagnosed with a genetic disorder every year (Baird et 
al. 1988; Chong et al. 2015). Mendelian birth defects are the primary cause for the death 
under the age of one (Chong et al. 2015).  
In clinics only well-established disorders can be diagnosed, whereas others cannot. 
Clinical diagnosis rate of Mendelian phenotypes is 50% (Chong et al. 2015). In children, 
diagnosis rate is as low as 11%. Besides, diagnosis success is another problem. There 
is a number of patients who are incorrectly diagnosed especially for rare diseases. Also, 
diagnosis periods are sometimes too long, which reduces the quality of life and results 
even in more severe conditions.    
With recent developments in WGS and WES, the average number of discovered genes 
associated to a monogenic Mendelian phenotype has been increasing. WES has been 
the most widely used in diagnostics success compared to karyotyping and genomic 
hybridization. The WES related diagnose success rates of 25% - 30% depends on the 
65 
 
recent discoveries on the association between genes and disorders. Thus, the future of 
the remaining 70% - 75% percent undiagnosed genetic disorders will depend on the 
findings on the gene-phenotype associations. As of today, Online Mendelian Inheritance 
in Man (OMIM) (McKusick 2007) database contains 7998 phenotypes described to have 
Mendelian basis. For ~45% of the Mendelian phenotypes, the molecular basis and 
responsible genes are still unknown.   
For autosomal dominant diseases, at least one parent should display the diseased 
phenotype. In autosomal recessive diseases, if the parents are healthy, the both must be 
carriers and there is 25% chance of inheriting both disease alleles to the child. 
Heterozygosity is inferred from the relative ratio of alleles in sequence reads. Normally 
50% is expected for heterozygous conditions.  
2.5.5 Orthologs and Paralogs in Disease 
Most of Mendelian phenotypes are caused by mutations in coding regions as they would 
have direct effects on proteins which are the fundamental biological molecules in cellular 
processes (Cooper et al. 2010).  
Evolution of genes mainly depends on two major mechanisms: duplication and loss. 
These two events work together to invent new genes. An existing gene is duplicated in 
cellular processes such as homologous recombination, retrotransposition, chromosomal 
and whole genome duplication, and replication slippage. Right after duplication, the new 
gene is likely to be identical to the original one in terms of sequence. However, since one 
of the two is not going to be critically necessary, one of them will likely accumulate 
mutations and “differentiate”. Before the newer duplicate diverges, it may function in the 
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same way of the original one. In that short time frame, the original gene may accumulate 
some mutations which would be compensated by the newer duplicate. Therefore a gene 
duplication may cause the original gene to be slightly diverged from the optimum fitness. 
In evolution, the redundancy of genes is not tolerated over long periods of time and one 
copy (usually the newly generated) either gains a new function or gets lost. These two 
sequences are still called homologous as one is derived from another. However, they are 
not orthologous as they are not resultant of a speciation event and they often have 
different biological functions. These genes are called paralogs and they are frequently 
associated with different phenotypes. For Mendelian diseases, it has been found that only 
one of the paralogous genes is associated with a disease (Figure 2-9) (Dickerson and 
Robertson 2012). Moreover, most of the Mendelian diseases are associated with the 
genes that have duplication history, which is likely to be caused by the slight divergence 
from the optimum fitness of the original gene upon duplication. 
2.5.6 In silico Variant Assessment  
Each human genome is estimated to contain 24,000-26,000 coding SNPs. Though 
substantial portion of the SNPs is synonymous, the non-synonymous part has a potential 
of changing the function of the associated protein. Each human genome contains 250-
300 loss-of-function variations affecting the function of the protein which in turn may 
cause a disorder mostly at homozygotic or compound-heterozygotic state (1000-
Genomes-Project-Consortium 2010). This is how rare genetic disorders arise. Although 
there are biochemical assays for well-known genetic disorders, not all of them are 
practical to be applied. Moreover, for cases where there are multiple suspects, testing 
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biochemical test-based diagnostic decisions are made only for well-established disorders. 
For the remaining genetic disorders, a high throughput screening is needed. For these 
reasons, molecular testing has started to be widely applied in clinics. DNA sequencing is 
a cheap and standard method, and can play a vital role in diagnoses of some cases. 
However, the analysis part can be challenging especially if the variant of interest is 
unusual. When encountering a novel non-synonymous mutation, the question that 
clinicians asks is: “Does the mutation affect the protein function?” To answer this 
question, the only easy way is to computationally predict the potential effect of the variant 
on the function.  
Figure 2-9 Gene family members are not involved in diseases equivalently.  
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There is a number of variant assessment tools (Table 2-2). Each of them has its own 
approach to evaluate the variants based on several features such as evolutionary history, 
structural and physiochemical importance of the substitutions.  Physiochemical property 
change in a substitution can only be a contributing parameter, as it is not accepted to be 
standard in every case of molecular interaction between amino acids. Structures on the 
other hand can be useful, because biological function of proteins depends on their 
structural stability. However, structures of only 36% of human proteins have been solved 
so far. For this reason, evolutionary information set the basics of the algorithms assessing 
non-synonymous variants.  Almost all of the protein-coding genes in human are 
conserved in vertebrate lineage (Aparicio et al. 2002; Mouse Genome Sequencing et al. 
2002). The evolutionary depth for human genes should allow for the observation of benign 
mutations to be present in wild type genomes of other organisms, which is then translated 
to human variant interpretation. Therefore, whether a site is conserved or not has a 
substantial contribution in decision making about the risk of a variant. The current tools 
select a subset of related sequences by eliminating too close and too distant sequences 
and they do not consider the phylogenetic relationship between them.   
Each of these automated tools uses their own approaches and as a result they lead to 
different predictions. The ratio of overlapping predictions for rare and novel variants 
between tools is fairly small (Chun and Fay 2009).  So, a single tool is insufficient to 
confidently categorize variants. If a stringent categorization is desired, agreement 
between tools can be used as proposed in Chun et al. However, agreed results from 




Name Reference Basis 
ConSurf (Ashkenazy et al. 2010) Evolutionary conservation 
FATHMM (Shihab et al. 2013) Evolutionary conservation 
MutationAssessor (Reva et al. 2011) Evolutionary conservation 
PANTHER (Thomas and Kejariwal 
2004) 
Evolutionary conservation 
PhD-SNP (Capriotti et al. 2006) Evolutionary conservation 
SIFT (Ng and Henikoff 2003) Evolutionary conservation 
SNAP2 (Hecht et al. 2015) Evolutionary conservation 
and predicted structural 
information 
SNPs&GO (Calabrese et al. 2009) Protein structure/function 
Align GVGD (Mathe et al. 2006) Protein structure/function and 
evolutionary conservation 
MAPP (Stone and Sidow 2005) Protein structure/function and 
evolutionary conservation 
MutationTaster (Schwarz et al. 2010) Protein structure/function and 
evolutionary conservation 
MutPred (Li et al. 2009) Protein structure/function and 
evolutionary conservation 
PolyPhen-2 (Adzhubei et al. 2013) Protein structure/function and 
evolutionary conservation 
PROVEAN (Choi and Chan 2015) Alignment and measurement 
of similarity between variant 
sequence 
nsSNPAnalyzer (Bao et al. 2005) Multiple sequence alignment 
and protein structure analysis 
Condel (Gonzalez-Perez and 
Lopez-Bigas 2011) 
Combines SIFT, PolyPhen-2, 
and MutationAssessor 
CADD (Kircher et al. 2014) Contrasts annotations of 
fixed/nearly fixed derived 
alleles in humans with 
simulated variants 
 
Table 2-2 Tools predicting effects of missense mutations on proteins. Modified from 
Richards et al. 
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Chun et al., SIFT predicts 53% of the studied variants as damaging (Figure 2-10). 
However, three tools agreed on only 7%. If the agreement of at least two tools criterion is 
used, 28% of variants are predicted as damaging. For this case, sensitivity reduces 
almost by half by using consensus of two tools. To sum up, neither a single tool nor a 
combination of tools is accurate enough to be confident and sensitive in predicting the 
damage of protein variants. This is one of the problems that clinicians are looking forward 
to having it solved.  
To conclude, with the easiness of sequencing, prognosis and diagnosis of human genetic 
diseases should be made by testing DNA. However, a new challenge in molecular biology 
is now to analyze the sequence data rather than retrieving them. Because evolution 
primarily takes effect at the protein level, protein based predictions are preferred by the 
scientific community. Around 19,000 protein coding human genes can only be targeted 
by a robust approach. Automated tools, however, lack accuracy. Though manual analysis 
on proteins cannot be applied on large-scale, case by case, it has a potential to result in 
more accurate predictions in experts’ hands, which in turn would be beneficial for the 





Copied from Chun and Fay, 2009. 
 
  
Figure 2-10 Inconsistent results produced by three different methods.  Predictions made by 
three methods. Numbers below and above are variants in the Venter genome for the complete 
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3.1 Abstract 
Summary 
Identification of domains in protein sequences allows their assigning to biological 
functions. Several webservers exist for identification of protein domains using similarity 
searches against various databases of protein domain models.  However, none of them 
provides comprehensive domain coverage while allowing bulk querying and their 
visualization schemes can be improved. To address these issues we developed CDvist 
(a comprehensive domain visualization tool), which combines the best available search 
algorithms and databases into a user friendly framework. First, a given protein sequence 
is matched to domain models using high specificity tools and only then unmatched 
segments are subjected to more sensitive algorithms resulting in a best possible 
comprehensive coverage. Bulk querying and rich visualization and download options 
provide improved functionality to domain architecture analysis. 
Availability 




oadebali@vols.utk.edu or ijouline@utk.edu 
3.2 Introduction 
The identification of protein domains is a key feature of protein sequence analysis. 
Several databases, notably Pfam (Punta et al. 2012), SMART (Letunic et al. 2009), COG 
(Tatusov et al. 2003), CDD (Marchler-Bauer et al. 2013) and others, develop and maintain 
domain models. Searching tools such as RPS-BLAST (Marchler-Bauer et al. 2013), 
HMMER3 (Eddy 2011) and HHpred/HHsearch (Soding 2005; Hildebrand et al. 2009) are 
used to match sequences to domain models present in a given database. The size of the 
protein sequence database grows dramatically, whereas its coverage by precomputed 
domain models increases very slowly (Rekapalli et al. 2012). Consequently, sensitive 
domain searches of sequences in bulk are necessary to improve computational coverage 
of the current and future protein sequence space. Despite the overwhelming success of 
the current state-of-the-art domain searching resources, three areas require further 
improvements: i) combining tools with high specificity and tools with high sensitivity in a 
single framework, ii) multiple query searches using highly sensitive (e.g. profile-to-profile) 
methods, iii) visualization of most relevant information in a responsive and interactive 
way.  
To address these issues, we have developed the Comprehensive Domain Visualization 
Tool (CDvist), a domain searching webserver specialized in maximizing domain coverage 




3.3 Implementation and Features 
Users submit protein sequences in FASTA format and each sequence is processed 
independently of each other on individual linux cluster nodes. Up to 500 queries per 
request are supported. The following domain search methods are implemented in CDvist: 
HMMER3 (Eddy 2011), RPS-BLAST (Schaffer et al. 1999; Marchler-Bauer et al. 2013), 
HHSEARCH (Soding 2005), and HHBLITS-HHSEARCH (Remmert et al. 2012). 
Transmembrane regions are predicted by either TMHMM (Sonnhammer et al. 1998) or 
Phobius (Kall et al. 2007).  Low complexity and coiled coil regions are predicted by SEG 
(Wootton 1994) and Coils (Lupas 1996) respectively. To improve domain coverage, rather 
than using the entire sequence, CDvist iteratively identifies regions without significant 
domain match (orphan segments) and submits each one of them to similarity search 
against a user-determined sequence of databases until the entire protein sequence is 
covered or all databases have been searched (Figure 3-1). The key principle of this 
process is that tools that have high specificity – HMMER against Pfam and RPS-BLAST 
against CDD – are used first. Only then, the sequence segments that were not confidently 
matched to any model are used to build profiles and subjected to more sensitive profile-
profile searches by HHsearch. Each algorithm can be turned on/off and the order of 
databases, and their significance thresholds, can be altered. This flexibility enables users 
to tailor the overall process for their specific purposes. Optional ‘domain split’ function 
splits the matched domain model if there is a considerable unaligned query region (5% 
by default) in the query-model alignment. This unaligned region is considered as an 




a) Primary sequence is used as input and transmembrane (gray), low complexity (magenta) and 
coiled-coil (green) regions are predicted. b) HMMER3 scan against Pfam database is executed 
and first domain architecture is built. c-e) HHblits followed by HHsearch is executed against c) 
Pfam,  d) PDB  and e) CDD databases. f) Domain coverage option: gray background represents 
the whole length of model whereas red bar displays the portion of the model that aligns with the 
query. Square points represent the domain positions that do not align with the query. g) Alignment 
option. Sequence is displayed to scale, and each bar stands for alignment quality at that position. 
The absence of the bar at a given position indicates gap in the alignment on query side. 
 
  
Figure 3-1 Workflow and visualization example. 
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A custom built JavaScript module powers the visualization on the client side with images 
in vector format (SVG) that are practical to edit, export as PDF and produce figures of 
publication quality. Results are displayed asynchronously for each query sequence 
submitted, which also allows the user to interact with the data before the completion of 
the entire request. Domain coverage bar provides information on what portion of the 
matched domain model is represented on the query sequence (Figure 3-1f). Alignment 
quality is represented as vertical bar for each position of the alignment. Gaps in the 
alignment indicate that the corresponding part of the query is not aligned with the model 
(Figure 3-1g). Scaled sequence information is mapped on the domain architecture, which 
is easily retrievable by zooming in on the browser. Drag feature allows user to align 
desired parts of batch data for further analysis. All this information is hosted in our 
webserver for over a week with a unique URL. Alternatively, the user can retrieve the 
HTML file to control the interactive feature visualizations locally on a web browser. JSON 
formatted files containing the information used to draw the graphics in the website are 
available for not only for each individual sequences but also for the entire input set as a 
single file. Finally, the log files for each run are available, which display the raw output of 
the whole process. Logs provide extra information on less significant hits which are not 
displayed visually. The databases are updated immediately upon their release. 
3.4 Discussion 
CDvist is designed to provide maximum domain coverage in protein sequences by 
bundling the best current domain search tools into a pipeline that exhaustively searches 
through a series of domain databases in an iterative fashion.  This methodology yields 
the most comprehensive domain architecture for a given protein sequence. Rich 
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visualization, download options and linear speed-up for bulk queries should be appealing 
to both biologists and bioinformaticians. This webserver would be especially useful for 
multi-domain proteins with rare or unique domain architectures and those prone to 
domain swap, where whole sequence similarity searches often yield uninformative and 
misleading results (Iyer et al. 2001). 
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4.1 Abstract 
Gene duplication and loss are major driving forces in evolution. While many important 
genomic resources provide information on gene presence, there are no tools for retrieving 
information on gene absence. Here, we present Aquerium, a platform for visualizing 
genomic presence and absence of biomolecules with a focus on protein domain 
architectures. The webserver offers advanced domain organization querying against the 
database of pre-computed domains for ~26000 organisms and it can be utilized for 
identification of evolutionary events, such as fusion, disassociation, duplication and 
shuffling of protein domains. The tool also provides alternative inputs of custom entries 
or BLAST results for visualization. Aquerium is available at http://aquerium.utk.edu. 
4.2 Introduction 
Phylogenetic profiling is a method to detect functionally or physically interacting proteins 
by inferring their co-presence/absence in hierarchically clustered species (Skunca and 
Dessimoz 2015). If genes are gained or lost together, it is likely that their products 
participate in the same biological pathway, meaning that they interact functionally. The 
method was first described by Pellegrini et al. who investigated the coevolution patterns 
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of Escherichia coli genes (Pellegrini et al. 1999). They demonstrated that gene groups 
that have similar occurrence profiles tend to be involved in the same pathways. 
Consequently, in addition to discovering protein-protein interactions, phylogenetic 
profiling can be used for protein function prediction. There has been a number of 
successful applications of this context-based method complemented by homology-based 
and experimental approaches (Kensche et al. 2008).  
Homology is inferred through sequence-based similarity searches. Domain organization 
comparisons can also be used to infer homology and to identify protein families. Domains, 
defined as minimal structural and functional building blocks of proteins, are capable of 
folding autonomously and evolving independently. Single domain proteins (SDPs) were 
likely dominant in the early stage of life, whereas multi-domain proteins (MDPs) are 
enriched with the complexity of organisms (Di Roberto and Peisajovich 2014). In SDPs 
the domain itself functions alone while in MDPs domains work in collaboration to perform 
the protein function.Domains can exist in various arrangements in a protein and this 
flexibility enriches the diversity of protein families. The complexity of MDPs can be 
attributed to the evolutionary dynamic nature of domains. The evolutionary events, such 
as domain innovation, loss, duplication, fusion, disassociation and shuffling enable 
proteins and eventually organisms to adapt to their environment (Kummerfeld and 
Teichmann 2005). Particularly, domain shuffling, rather than de novo inventions from 
disordered sequences is the major evolutionary event to generate novel proteins (Di 
Roberto and Peisajovich 2014). It was suggested that the total number of unique protein 
domains decreased in the course of eukaryotic evolution. For instance, last eukaryotic 
common ancestor (LECA) had a larger unique domain pool than any of the current 
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species (Zmasek and Godzik 2011). Also, in mammals, a drop in the domain pool has 
been observed compared to the ancestral repository (Zmasek and Godzik 2011). These 
observations suggest that reusing protein domains in various modifications and 
rearrangements drives protein evolution.  
More complex organisms have relatively more complex MDPs (Das et al. 1997; Wolf et 
al. 1999). This correlation may explain why gene number does not increase with 
organismal complexity (Koonin et al. 2002). Therefore, in order to understand complex 
networks, it is important to investigate the function of domains and how they collectively 
work together. Inferring the evolutionary relationships between domains is critically 
important in order to identify their functions and interactions. 
Domains in protein sequences can be identified computationally, e.g. using. HMM 
(Hidden Markov Model) profiles. Pfam (Protein Families) database is a large collection of 
HMMs and underlying tools, which is one of the most popular resources for identifying 
protein domains (Finn et al. 2014). Pfam-A, a manually curated subset of the database, 
currently (version 28.0) contains 16230 domain models. Another HMM utilizing resource, 
TIGRFAM, contains models for many full-length proteins so that it provides an easy 
detection for protein families (Haft et al. 2013).  
Biological networks diverge from their ancestor by protein or domain gaining/losing and 
domain shuffling. Such diversity patterns can be detected by comparative analysis of 
domain architectures. For this reason, retrieving the domain organization of interest and 
visualizing its taxonomic distribution are the crucial steps in understanding the functional 
relationships within networks. In addition to Pfam, several other tools,  such as SMART 
(Letunic et al. 2015), CDART (Geer et al. 2002), DAhunter (Lee and Lee 2008) and 
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PfamAlyzer (Hollich and Sonnhammer 2007), provide domain architecture querying. 
These tools specialize in searching for protein homologies through similar domain 
architectures. However, none of the current resources allows advanced domain 
architecture querying while visualizing domain presence and absence in the 
phylogenomic context. Furthermore, none of the tools has an option to visualize genomic 
distributions of multiple queries at once.  
To address these problems, we developed Aquerium (architecture querying podium), a 
tool enabling biologists and bioinformaticians to understand the domain-based 
evolutionary history of proteins. 
4.3 Implementation 
Genomes from the NCBI genomes database (as of 12th of December 2014) which also 
had assembly records in the NCBI assembly database were selected. GenBank records 
for each genome was retrieved from the NCBI Entrez Genome database (Gibney and 
Baxevanis 2011). We created a proteome collection for each genome. In order to manage 
isoforms in eukaryotes, each protein was categorized under the gene identifier that it is 
coded by. If a gene has at least one protein isoform matching the query, the tool returns 
true. If several isoforms match with a query, only one of them is taken into account in 
order to eliminate redundancy in count number. SeqDepot database (Ulrich and Zhulin 
2014) was used locally to retrieve the pre-computed domain architectures from Pfam 
versions 27.0 and 28.0 and TIGRFAM versions 14 and 15. Local SeqDepot database was 
updated by running HMMER3 (Mistry et al. 2013) searches against domain databases for 
uncovered proteins.  
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The NCBI taxonomy database (Federhen 2012) was used to build the tree. In addition to 
eight major taxonomic ranks, we also included the five eukaryotic supergroups (Koonin 
2010). Protein GI number to taxonomic id mapping was performed using the local 
database that was retrieved from NCBI taxonomy ftp source (Federhen 2012) and daily 
updated. The resulting taxonomic tree can be visualized by using two sets of genomes: 
species-representative and full sets. Species-representative set (4934 genomes) was 
built by selecting only one representative for strains determined by their species-level 
taxonomic ids. The genomes with the largest number of genes among strains were 
selected as representative. The full set was composed of 26618 organisms. 
The data has been organized in a document based MongoDB database. Custom Python3 
scripts were developed for searching the database. JavaScript was implemented in 
HTML5 to visualize the results. The final figure is drawn in Scalable Vector Graphics 
(SVG).  
4.4 Features 
Advanced domain architecture querying 
MDPs have various domain arrangements. In some proteins, the domain order is 
conserved, whereas other proteins are subjected to domain shuffling, duplication and 
loss. Diverged domain architectures might be indicators of modified or adapted function. 
For these reasons, it is important to enable extensive architecture querying. 
Aquerium allows users to select the domain of interest, called “key domain”, to initialize 
the search.  This field is mandatory and the algorithm will retrieve proteins that have at 
least one key domain. In the query page, a condition (“if” statement in Python syntax) can 
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be specified to customize the query in terms of domain content and organization. This 
condition is used for enriched querying in which presence and absence of other domains 
can be examined. Moreover, the order of the domains, from N- to C-terminus can be 
specified and only proteins satisfying the given condition are retrieved. Specifying a 
condition is not necessary if the user is interested only in the presence and absence of 
the key domain. Domain search can be performed on species-representative and full sets 
and these sets can be filtered based on taxonomic units. 
Visualization 
Species are clustered based on their taxonomic ranks and represented as a sunburst tree 
on which each taxonomic class is drawn as an arc. The length of arcs scales to represent 
the number of species which are eventual descendants of the node. On the tree, there 
are nine taxonomic layers representing the major taxonomic ranks and supergroups for 
eukaryotes (Koonin 2010). After taxonomic ranks, each outer ring represents the 
requested query. If there is any match in the corresponding genome, there will be a 
colored flag aligning with the organism on an outer circle.  
In the “zoom” mode each taxonomic node, represented by an arc, is zoomable on click. 
The sunburst is redrawn and shows only the selected node and its children in a circular 
layout. Extensive coloring options are offered on the fly allowing to produce publication-
quality figures. The coloring of flags can also be performed as a heatmap depending on 
the quantity of each flag. Multiple layers can be visualized on the same tree. Users can 
visualize up to 10 outer layers on the same tree. In the “Arc” mode, clicking on a node will 
redirect the user to another webpage where they can visualize the associated organisms 




The sunburst tree can be exported in scalable vector graphics (SVG). The compiled data 
can be downloaded in semicolumn separated file (CSV) format, which includes the 
taxonomic identifiers and the number of occurrences for each organism. JSON file 
containing taxonomically classified organism information is also available to retrieve. 
Moreover, protein sequence (in FASTA format) download option for desired taxonomic 
unit is available.  
Custom input for visualization 
In addition to protein domains, the sunburst tree can be produced with any other types of 
genomic data. Users can input a custom table containing NCBI taxonomic id followed by 
numeric or binary occurrence of profiles in CSV format and visualize the results. Up to 10 
flag layers can be visualized in a single request. 
Aquerium web server also offers visualizing blastp results on the tree. Users must 
download xml version of the BLASTp (Boratyn et al. 2013) results from NCBI and upload 
it to the relevant link on the Aquerium web page. Filtering the blast hits are possible by 
setting up thresholds for e-value, query and subject coverage. Additionally, protein GI 
number list can also be used as an input. 
4.5 Illustrations 
In order to exemplify Aquerium performance, we presented two independent test cases 
which show potential applications to similar problems. 
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Identification of a domain fusion event. Amino acid kinase (AA_kinase) and Aldehyde 
dehydrogenase (Aldedh) domain families are universal and seen in all domains of life with 
minor absences in few parasitic clades. These domains usually comprise a single domain 
protein, such as E. coli glutamate-5-kinase and γ-glutamyl phosphate reductase. Human 
δ-1-pyrroline-5-carboxylate synthetase has evolved as a fusion product of AA_kinase and 
Aldedh domains (Marcotte et al. 1999). Figure 4-1 shows the presences and absences of 
these domains. The outmost layer shows the occurrence of these two domains together 
in a single protein. In all supergroups of eukaryotes, these two domains are fused. The 
observed pattern of inheritance suggests that the fusion of these domains has occurred 
in the common ancestor of eukaryotes, and the common ancestor of fungi lost it.  
Coexisting proteins and abundance correlation. The signaling complex in bacterial 
chemotaxis, which has been conserved since the common bacterial ancestor (Wuichet 
and Zhulin 2010), consists of MCPs (chemoreceptors), CheA (a kinase) and CheW (an 
adaptor). These three proteins are found together in 98% of genomes that encode 
chemotaxis genes (Wuichet and Zhulin 2010). Figure 4-2 shows the phlyetic distributions 
of these three proteins. Satisfactorily, in the vast majority of cases, all three proteins are 
either present or absent in genomes indicating the presence or absence of chemotaxis 
as a cellular function. This test case serves as a control for true negatives. Relative 
abundances of these proteins in genomes (some genomes have several different types 
of the signaling complex encoded by different sets of genes) also correlate.  This is 
visualized using the heatmap option revealing the number of hits for each organism. 




Fused proteins containing both Aldedh and AA_kinase domains are found in all represented 
eukaryotic supergroups, suggesting that the fusion occurred in the last eukaryotic common 
ancestor (LECA). 
  




Chemotaxis proteins MCP, CheA and CheW are known to be interacting with each other. They 
show similar patterns of not only occurrence but also relative abundance. 
  




The presence of genetic material in a genome is almost never questioned except for the 
possibility of contamination. On the other hand, the absence is always questioned and 
negative information should be treated cautiously.  Being confident about the absence of 
particular genes/proteins/domains in genomes is challenging for two main reasons: (i) 
genomes may be incomplete, erronenus or contaminated and (ii) genes may not be 
identified due to computational limitations. However, the absence of two or more 
genes/proteins/domains that is consistently observed in independent samplings strongly 
suggests that the absence is true (Figure 2). Independent co-evolution can be identified 
by large-scale analyzes; as the number of samples increases, the likelihood of finding 
independent cases also increases. 
Aquerium enables exploring a variety of phenomena in a genomic context, ranging from 
evolution of individual domains to inferring potential protein-protein interactions, by 
placing a nearly equal weight on the presence and the absence of genomic entities, such 
as genes, proteins and their domains.Thus, this tool is expected to be useful to many 
biologists working within the genomic landscape. 
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5.1 Abstract 
Predicting the phenotypic effects of mutations has become an important application in 
population genetics studies and clinical genetic diagnostics. Computational tools, such as 
PolyPhen and SIFT, utilize comparative genomics to evaluate the behavior of the variant 
over evolutionary time and assume that variants seen during the course of evolution are 
likely benign in humans. However, these tools do not take into account 
orthologous/paralogous relationships. Paralogs have dramatically different roles in 
Mendelian diseases. For example, while inactivating mutations in the NPC1 gene cause 
the neurodegenerative disorder Niemann-Pick C, inactivating mutations in its paralog 
NPC1L1 are not disease causing and moreover are implicated in protection from coronary 
heart disease. Here we show that by removing the NPC1 paralogs from the analysis we 
can improve the overall performance of categorizing damaging and benign single amino 
acid substitutions. We anticipate that this approach will improve the interpretation of 





With the revolutionary developments in sequencing technologies (Katsanis and Katsanis 
2013), molecular testing is now widely used to confirm or support clinical diagnosis.  Being 
cheap, fast and accurate, DNA sequencing is a promising method for prognosis, 
diagnosis, personalized therapeutics and identifying unknown cause in genetic disorders 
(Ng et al. 2010; Chang and Li 2013; Katsanis and Katsanis 2013). There are several 
approaches to evaluate the effect of a variant: (i) evidence-based, (ii) frequency-based, 
(iii) functional (variants with obviously drastic consequences such as nonsense and 
frameshift mutations), and (iv) predictive (Oliver et al. 2015). Being knowledge-based, the 
first three approaches are often successful in determining the effects of variants. 
However, they are limited when it comes to the variants of unknown significance (Katsanis 
and Katsanis 2013). For novel variants, which comprise the vast majority of coding 
variation (Tennessen et al. 2012), in silico prediction is a quick way is to estimate potential 
consequences. There is a number of computational tools, such as PolyPhen (Adzhubei 
et al. 2010) and SIFT (Ng and Henikoff 2003), that are frequently used to evaluate genetic 
variations not only in research laboratories, but also in clinical practices. However, they 
are not yet at the level of desired performance in terms of sensitivity and specificity, even 
for well-studied monogenic Mendelian diseases (Jordan et al. 2010; Sunyaev 2012; Oliver 
et al. 2015). Therefore, there is still a need for improvement in computational prediction 
of variant effects (Oliver et al. 2015).  
Current tools that are automated, fast and applicable to all human protein-coding genes 
consider the following key parameters: sequence conservation, structural constraints and 
physiochemical properties of amino acids. Risk estimation is largely dependent on the 
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molecular conservation, which is inferred from comparative sequence analysis (Ng and 
Henikoff 2006). The motivation behind using molecular conservation as a key estimate is 
the fact that deleterious mutations cause a reduction of evolutionary fitness; therefore, 
they are not selected for and are not observed in homologs in other organisms (Jordan 
et al. 2010). In order to identify homologous sequences in other organisms, current tools 
employ automated sequence similarity searches followed by clustering. Consequently, 
sets of similar sequences that are used in the downstream analysis usually include both 
orthologs and paralogs (Adzhubei et al. 2010). This approach is based on the argument 
that disease-causing substitutions far more often affect protein structure than function 
(Wang and Moult 2001), and while paralogous proteins may have a slightly different 
function, their structure is fully conserved. 
However, recent studies revealed that the roles of paralogous genes in disease and 
health are different. In most of the cases of Mendelian diseases, among gene family 
members, only one gene is associated with the disease, while others do not have any 
role in that particular disorder (Dickerson and Robertson 2012). In 87% percent of the 
gene pairs, only one pair is associated with disease, and this trend is observed in gene 
families with more than two members. Duplication of genetic material is the primary 
source of new protein-coding elements rather than de novo invention. Once a gene is 
duplicated, purifying selection pressure on one of the copies is relaxed and that gene 
becomes more prone to accumulating mutations. This divergence can lead to sub-
functionalization, neo-functionalization or non-functionalization of the paralogous gene 
(Lynch and Conery 2000) often resulting in their different roles of paralogs in disease.  
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This precise pattern is observed in Niemann-Pick disease type C (NP-C), which is a 
neurovisceral lysosomal lipid storage disease with an incidence of 1:100,000 (Vanier 
2010; Patterson et al. 2012; Jahnova et al. 2014). NP-C is inherited in autosomal 
recessive pattern and caused by mutations in either NPC1 or NPC2 genes (Vanier 2015). 
NPC1 and NPC2 proteins work in concert to transport cholesterol from the 
endosomal/lysosomal compartment (Sleat et al. 2004; Vanier 2010). Homozygous loss 
of function in either protein perturbs lipid homeostasis, specifically by causing sterol and 
sphingolipid accumulation in the late endosomal/lysosomal (LE/L) compartment of cells, 
which results in pathogenicity. 95% of affected individuals carry pathogenic mutations in 
the NPC1 gene (Patterson et al. 2012), which recently attracted attention because of its 
role in Ebola virus entry (Carette et al. 2011; Cote et al. 2011; White and Schornberg 
2012).  By contrast, the NPC1 paralog, NPC1L1 is not associated with the disease. On 
the contrary, inactivating mutations in NPC1L1 reduce the risk of coronary heart disease 
(Myocardial Infarction Genetics Consortium et al. 2014). NPC1 deletion in mice causes 
hearing loss (King et al. 2014), defects in retina (Yan et al. 2014), and deficiency in 
cerebellum development (Nusca et al. 2014), whereas NPC1L1 deficiency protects ApoE-
/- mice against atherosclerosis (Davis et al. 2007).  Clearly, these two paralogs do not 
share identical functions and have different roles in health and disease. 
Diagnosis of NP-C is challenging because of the heterogeneity in symptoms and clinical 
presentation (Vanier 2010). Until recently, the diagnostic standard was filipin staining of 
unesterified cholesterol in fibroblasts obtained by skin biopsy (Bornig and Geyer 1974; 
Vanier and Latour 2015). This test, however, is able to make a definitive diagnosis in only 
~2/3 of cases. NP-C diagnostics has been significantly improved through the discovery 
111 
 
of cholesterol oxidation products (“oxysterols”) that are elevated in the plasma of NP-C 
subjects (Porter et al. 2010). The plasma oxysterol assay detects >97% of cases with 
100% sensitivity (Jiang et al. 2011). DNA sequencing offers another tool for NP-C 
diagnostics, but in practice detects only ~85% of NP-C cases due to the large number of 
private and non-coding sequence mutations (Stampfer et al. 2013). If a variant found in 
genetic testing has not been previously found to be disease causing, it is followed by risk 
estimation for pathogenicity. For novel missense mutations, in silico tools are 
indispensable to predict potential NP-C. However, each of the tools uses a different 
algorithm and some of them even use different data sets to evaluate the variant effect. 
For this reason, substantial inconsistencies between in silico tools are observed 
(Castellana and Mazza 2013). In case of a contradiction, deciding which software to trust 
in pathogenicity prediction remains a challenge. Researchers usually rely upon 
agreement between several tools, which has the effect of increasing specificity while 
decreasing the sensitivity (Wassif et al. 2015). Moreover, computational risk prediction 
tools that use conservation information do not discriminate between orthologous and 
paralogous proteins (Adzhubei et al. 2010), and, thus, include NPC1 paralogs, such as 
NPC1L1, in their analysis. Although including paralogs in risk estimating datasets is 
convenient (this eliminates computationally demanding and often non-trivial steps to 
separate orthologs and paralogs), such simplification confounds the function-specific 
signal.  
NP-C disease caused by NPC1 mutations is an ideal case study to understand the effects 
of paralogs in predicting disease causing mutations, because of a dramatic consequence 
of the duplication event that yielded NPC1L1. Moreover, many experimentally validated 
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disease-causing mutations as well as alleles with high frequencies that are likely to be 
benign are known for this gene. We hypothesized that it is possible to predict the 
pathogenicity of single amino acid variants (SAVs) in NPC1 using only functionally 
equivalent human NPC1 (HsNPC1) orthologs.  
In this study, we established the precise evolutionary history of the NPC1 gene and 
identified evolutionary events that have likely affected its function. We used this 
information to build a computational approach, which showed improved accuracy in 
categorizing damaging and benign single amino acid substitutions in NPC1. 
5.3 Results 
Distinct Clusters of NPC1 Homologs Suggest Different Functions 
NPC1 protein is predicted to have 13 transmembrane (TM) regions with 3 luminal 
domains. The crystal structure of the N-terminal domain has been solved with bound 
cholesterol, implicating this domain is involved in cholesterol binding and transport (Kwon 
et al. 2009). The pentahelical sterol-sensing domain, which resides between TM3 and 
TM8, likely responds to membrane cholesterol content and is required for cholesterol 
egress from the lysosome. There are 9 human genes, which share homology through 
their sterol-sensing domains and are identifiable in conventional sequence similarity 
searches initiated with NPC1: NPC1, NPC1-L1, PTCH1, PTCH2, PTCHD2, PTCHD3, 
PTCHD4, SCAB SREBF and DISP. These related proteins also share the “Patched” 
domain, which has a role in cholesterol-dependent processes. By contrast, domain 
architectures of these proteins show significant differences, where only NPC1 and NPC1-
L1 contain the N-terminal cholesterol-binding domain (Figure 5-1A). A phylogenetic tree 
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constructed from the multiple sequence alignment of all Patched domain proteins shows 
distinct clades, where the NPC1-NPC1L1 clade is clearly separated from the rest of the 
Patched-containing sequences (Figure 5-1B).  These findings strongly suggest that other 
Patched-containing sequences should not be taken into account when examining 
function-specific characteristics of NPC1. In contrast, automated tools often include such 
functionally unrelated sequences in their datasets (see appendix). 
Major events in NPC1 evolution  
The NPC1 gene is found in four of the five eukaryotic supergroups - unikonta, plants, 
chromalveolata and excavates – and is missing from Rhizeria. Phylogenetic analysis of 
NPC1 protein shows that the NPC1 gene followed vertical evolution. Thus, it is likely that 
NPC1 was present in the last eukaryotic common ancestor (LECA). Multiple gene 
duplication events are observed in a range of taxonomic ranks from superorder to species 
level: among 397 species having NPC1, 195 (49%) have more than one copy (see 
appendix).  
In the common ancestor of gnathostomata (jawed vertebrates), the NPC1 gene was 
duplicated giving rise to the “NPC1-like” protein, which is present in most jawed 
vertebrates including humans (named NPC1L1). The NPC1L1 clade is greatly diverged 
from the root when compared to the gnathostomatan NPC1 clade (Figure 5-2). NPC1 is 
present in each organism that has NPC1-L1; however, the opposite is not true. NPC1L1 
is missing from some jawed vertebrate genomes. Moreover, the NPC1L1 clade has a 
longer average branch length from its root indicating a greater divergence (Figure 5-2). 





A) The domain architectures of human Patched domain-containing proteins were retrieved using 
the CDvist web server. Boxes with white background represent PFAM domains. Cholesterol-
binding domains (in blue) were retrieved using a PDB database profile.  Cholesterol-binding 
domain was found exclusively in NPC1 and NPC1L1. B) Some pairs such as PTCH1-PTCH2, 
NPC1-NPC1L1, PTCHD3-PTCHD4 have a relatively recent common ancestor, whereas the other 
proteins are related to each other more distantly, as they are represented as single clades on the 
phylogenetic tree. According to the phylogenetic tree the NPC1-NPC1L1 clade is clearly 
separated from other patched domain containing sequences. 
\ 
  
Figure 5-1 Relationships between Patched domain-containing proteins. 
115 
 
from that of NPC1, which is further supported by the observation that no mutations in 
NPC1-L1 have been associated with the Niemann-Pick C disease.  
We observed another duplication in neoptera. As in gnathostomata, one of the two copies 
diverged from the original protein. Except for Drosophila willistoni, each neopteran 
genome containing the “diverged” copy also has the “original” version of the NPC1 gene. 
However, the diverged copy is dispensable for some flies. In addition, because the 
diversified neopteran NPC1 shows higher within-clade divergence, it is likely to have 
gained a different function compared to the original protein, as seen in vertebrates (see 
appendix). 
In fungi and amoebozoa, several duplications took place, but only at the species and 
genus level. So there was no major duplication event in these kingdoms.  
In plants, there was a NPC1 duplication in the common ancestor of flowering plants. More 
than one paralog is observed in Pentapetalae. However, the distances of two clades from 
the root are comparable (Figure 5-2). Furthermore, some organisms have only one 
version of the gene from either clade, which suggests that one paralog is sufficient and 
neither copy is indispensable. Internal diversity of two clades were not significantly 
different from each other. Therefore, the clades may not have gained significantly different 
functions. For this reason, the Homo sapiens NPC1 (HsNPC1) orthology assignment 
cannot be precisely performed in plants. 
Unikonts (metazoa, fungi and amoebozoa) and plants have the full-length NPC1 protein 




The star is placed at the root of full length NPC1. On the left side, the black markers represent 
the closest NPC1 to the root for each organism. Green markers (Set 2) show the orthologs 
whereas red markers point to paralogs. Blue markers represent sequences which are ambiguous 
in terms of orthology. Gray-shaded clade contains short version of NPC1. 
Figure 5-2 Maximum-likelihood phylogenetic tree of NPC1 proteins and described sets. 
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Dictyostelium, where two additional TM regions are inserted after TM-1 (see appendix). 
They all accommodate a lumenal N-terminal domain that binds to cholesterol. However, 
in Naegleria gruberi (excavate) and in most chromalveolates, the N-terminal cholesterol-
binding domain is missing resulting in a shorter protein with 12 TM regions (see 
appendix). We found that all organisms that lack the NPC1 N-terminal domain, have a 
separate protein (~ 300 amino acids) encoded in their genomes, which is homologous 
(~30% identity, ~50% similarity) to the N-terminal domain of the full-length HsNPC1. 
Oomycetes have both “full” and “short” versions of NPC1. In the phylogenetic tree, these 
two versions are distinctly separated. Except for Nannochloropsis gaditana (which has an 
atypical NPC1 with no sterol-sensing domain), all organisms having the short version of 
NPC1 protein, also have the separate cholesterol binding protein. Moreover, the separate 
cholesterol binding protein is found exclusively in the organisms that have the short 
NPC1. The separate cholesterol binding protein is predicted to have a signal peptide at 
the N-terminus and a TM region at the C-terminus. Thus, concatenation of the separate 
cholesterol-binding protein and the short version of NPC1, substantially resembles 
HsNPC1. Exclusive coexistence of these two proteins suggests that they interact and 
function similarly to the full version of NPC1. The existence of both versions in oomycetes 
and the vertical evolutionary patterns suggest that both versions could have been present 
in LECA, where either fusion or dissociation could have occurred; then only one version 
was kept in all organisms, except for oomycetes, where both were kept. 
In addition to major duplication events, in each kingdom, there were also species and/or 
genus level duplications. In such cases, we usually observe that in an organism, one copy 
evolves slowly to keep the original function, while the extra copies, which are not prone 
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to purifying selective pressure, diverge faster. We used the distance measurements from 
the common ancestor node in the phylogenetic tree to determine the “incomparably least 
diverged” (slowest evolving) gene, which in turn enables us to find the functional 
orthologs. However, in some cases orthology assignment was inconclusive due to 
comparable divergence behaviors.  
NPC1 was lost in many parasites including whole clades, such as microsporidia (fungi) 
and apicomplexa (chromalveolata). Except for Naegleria gruberi, all species sequenced 
in the excavate supergroup are parasitic (Trypanosomatidae family, Trichomonas 
vaginalis and Giardia intestinalis) and contain no NPC1 in their genomes.  
Defining HsNPC1 Functional Orthologs  
Products of orthologous genes are very likely to perform the same function. Therefore, 
distinguishing HsNPC1 orthologs from other homologous proteins is critical in order to 
identify potentially pathogenic variants specifically affecting HsNPC1 function. Detailed 
analysis of the phylogenetic tree of all NPC1 homologs guided HsNPC1 orthology 
assignment. The clades retaining the original NPC1 function were determined based on 
the agreement of three lines of evidence. First, we compared the distances of duplicated 
clades to the full-length NPC1 root (Figure 5-2) to identify which one is less diverged. 
Second, we compared the organism content of the clades. If a clade is subset of another, 
then the superset clade was considered the “original” one representing HsNPC1 
orthologs. Finally, diversity within the clades was assessed: the less diverged clade is 
more likely to be ancestral (see appendix). When all three criteria agree, HsNPC1 
orthologs can be identified with confidence. However, in some cases, the sequence 
divergence information was inconclusive. In those cases, none of the clades was a subset 
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of another. Moreover, the diversity within the clades was comparable. Consequently, 
these sequences were classified as “ambiguous” and they were not included in the set of 
HsNPC1 orthologs. 
Evaluating Missense Mutations in HsNPC1: the Scoring Algorithm 
Our master multiple sequence alignment (MSA) included all homologs, such as paralogs 
and short version duplicates. We divided the master MSA into three sets grouped by the 
orthology relationships (see Figure 2 for details). The phylogenetic clade containing 
HsNPC1 after the most recent major evolutionary event, which is the birth of NPC1L1 in 
gnathostomata, was considered as the core alignment. Not surprisingly, this alignment 
set had a high level of sequence conservation. We refer to this alignment as “Set 1”. Set 
1 is given the highest importance in the evaluation algorithm. Set 2 includes Set 1 and 
also other sequences which have unambiguous one-to-one orthology with HsNPC1. 
Finally, Set 3 contained all HsNPC1 homologs, including paralogs and “ambiguous” 
orthologs, except for the short versions of NPC1. 
In order to predict the effect of missense mutations on HsNPC1 function, we propose an 
algorithm (SAVER: Single Amino Acid Variant Evaluator) that provides binary output from 
the MSA analysis of Sets 1 and 2 (Figure 5-3). In the scoring part, Set 1 is given the 
highest weight, because it contains HsNPC1 and its orthologs that evolved after the most 
recent duplication (MRD). The birth of many Mendelian diseases correlates with the time 
of MRDs (Dickerson and Robertson 2012). However, using only Set 1, which is limited in 
our case to bilaterian genomes, would not be sufficient in collecting the entire ancestral 
information. For this reason, Set 2 was used to compensate for the lack of evolutionary 
depth in Set 1. Because Set 2 was carefully constructed from sequences that are likely 
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to conserve the ancestral function of NPC1, the amount of false signal it introduces is 
limited. Furthermore, the possibility of false signals in Set 2 was addressed by lowering 
its priority. Because sufficient evolutionary depth was reached with set 2, specificity was 
not affected drastically by excluding Set 3-only sequences. 
Sequencing and aligning errors are key factors causing misinterpretation. For example, 
a pathogenic variant can be categorized as benign, when the corresponding position in 
MSA appears variable due to several misaligned sequences. For this reason, working 
with the cleanest possible data set, a nearly perfect alignment and well-constructed 
phylogenetic trees is critical in assessing the mutations. Ab initio elimination of sequences 
that have misaligned regions is not an optimum solution, because these sequences may 
also contain well-aligned regions carrying important information. In our approach we apply 
positional masking of misaligned regions, so that well-aligned positions in these 
sequences are taken into account. Another challenge in eukaryotic sequence comparison 
is dealing with isoforms, which are different protein products of the same gene due to 
alternative splicing.  The isoforms can redundantly dominate the signal and cause artificial 
conserved positions. Moreover, on the borders of alternative splicing, the unrelated 
sequences of isoforms can be aligned together. We resolve this issue by choosing a 
representative isoform for each gene. Selection of a representative isoform depends on 
the queried position, in order to rule out the errors that alternative-splicing prediction can 
cause.  
For a single amino acid substitution from AA0 to AA1, scoring algorithms usually use the 




P: position of the substitution; AA0: original amino acid; AA1: replacing amino acid. 
Figure 5-3 SAVER algorithm workflow. 
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with substitutions, we propose to count how many times a given replacement has 
occurred independently, so a single evolutionary event would not be counted multiple 
times. Distinguishing between single and multiple independent substitutions is critical, 
because multiple independent substitutions, occurring in different clades, suggest that a 
position tolerates mutations, whereas a single substitution compensated by a suppressor 
mutation can be in a potentially “irreplaceable” position. It is important to stress that such 
information can only be obtained from well-edited multiple sequence alignments and well-
built phylogenetic trees that require substantial manual work. 
Improved success in distinguishing between damaging and benign SAVs. 
We scanned literature to retrieve known NPC1 variants. Only single amino acid 
substitutions were taken into account. Only biochemically validated NP-C causing 
mutations were considered as “damaging” variants. Recently published frequencies of 
HsNPC1 variants from several exome sequencing data sets (Wassif et al. 2015) were 
used to define the benign mutation data set. We selected the common variants that have 
never been shown as pathogenic in any study, and that have frequency greater than 
0.028%, which is the frequency of the most commonly reported pathogenic variant, 
I1061T. Our compiled control set contained 166 damaging and 21 benign SAVs (see 
appendix).  
We tested our approach in comparison with leading automated tools: PolyPhen-2, SIFT 
and PROVEAN (Ng and Henikoff 2003; Adzhubei et al. 2010; Choi and Chan 2015). The 
results indicate that our approach outperforms other tools (i) in terms of sensitivity (~10% 
improvement), while causing a relatively low cost in specificity and (ii) in terms of the 
overall quality, as measured by the Matthews correlation coefficient (Table 5-1). The 
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drastic improvement in sensitivity can be explained by the fact that our method eliminates 
the false evolutionary signals introduced by functionally diverged sequences that are 
included in the analysis by other tools (see appendix).   
We also applied our method to all theoretical amino acid substitutions in NPC1. 24282 
(1278 positions in NPC1 sequence X 19 amino acid substitutions) theoretical SAVs were 
evaluated by our approach in comparison with the well optimized automated methods 
described above (see attachment). Ultimately, our method predicts 81% of the variants 
as damaging, while PolyPhen-2, PROVEAN and SIFT predict 60%, 70% and 66% as 
damaging, respectively. Because we suspected that our approach over predicts 
damaging variants, we adjusted the cutoffs of other tools to fix the damaging rate at 81%. 
After the adjustment, the performance of two methods (PolyPhen-2 and PROVEAN) was 
improved; however, none of them reached the quality of our approach, as measured by 
Matthews Correlation Coefficient value. Comparison between receiver operating 
characteristics of the tools and our “sensitivity - false positive rate” datum, shows a clear 
distinction of our result from the general trend of the others (see appendix). 
An example of how inclusion of paralogous sequences negatively affects the prediction 
is shown in Figure 4. Known pathogenic mutations, N968S, G986S, G993A and M995R 
(see appendix) are predicted as benign by all three automated tools, because the same 
substitutions are found in NPC1L1 paralogs that are included in their MSA sets (Figure 
5-4). Figure 5-5 shows topology of the human NPC1 where the positions are colored 
based on the numbers of allowed amino acids at that position by our approach. This risk 
map provides clues about the functionally critical regions of HsNPC1 (see appendix) and 











































 TP FN TN FP 
           
SAVER 157 9 14 7 0.95 0.67 0.04 0.91 0.95 0.59 
PP2 139 27 15 6 0.84 0.71 0.04 0.82 0.89 0.42 
PROVEAN 141 25 15 6 0.85 0.71 0.04 0.83 0.90 0.43 
SIFT 135 31 18 3 0.81 0.86 0.02 0.82 0.89 0.48 
PP2adj 159 7 12 9 0.96 0.57 0.05 0.91 0.95 0.55 
PROVEANadj 153 13 12 9 0.92 0.57 0.06 0.88 0.93 0.46 
SIFTadj 150 16 11 10 0.90 0.52 0.06 0.86 0.92 0.38 
 
The cutoffs distinguishing between “damaging” and “benign” variants, are changed in the methods 
which have subscripted with “adj” abbreviation based on the output of the SAVER computation. 
SAVER and other “adjusted” tools yield 81% damaging rate in all theoretical amino acid 
substitutions on HsNPC1.  TP: True positive; FN: False negative; TN: True negative; FP: False 
positive. 
  




attachment. We have built a web-based application for querying single amino acid 
variants in NPC1, which can serve as a reference for clinicians when describing novel 
NP-C causing mutations. It is freely available at http://genomics.utk.edu/saver/npc1.html. 
5.4 Discussion 
In this work, we showed that it is possible to get closer to the desired level in predicting 
the effects of missense mutations by carefully analyzing the evolutionary history of a 
gene. A clear improvement is accomplished by taking into consideration only function-
specific orthologous protein sequences. Remote homologs and paralogs that are likely to 
be functionally diverged should be removed from the analysis. In selecting functional 
counterparts, specific criteria based on a thorough phylogenetic analysis must be used.  
The proposed approach heavily depends on manual work (constructing high-quality 
datasets, alignments, trees and defining orthologs and paralogs) as well as reasoning, 
which depends on the output of a particular computational step. Thus, for now, this 
approach cannot be fully automated and will not replace any of the available automated 
tools. However, revealing common trends and problems in identifying functional orthologs 
and testing this approach on other well-defined monogenic Mendelian diseases, should 
lead to the development of the next generation of predictive automated methods directly 






Blue shaded sequences are HsNPC1 orthologs and the rest are paralogs. For each tool, 
a red marker represents “predicted as damaging”, whereas green marker stands for 
“predicted as benign”. Residues highlighted in red are the potential causes of predicting 
pathogenic variants as benign. 
  
Figure 5-4 An alignment window illustrating false effects of paralogs in predicting 




Color scale from red to green ascendingly shows the number of amino acid substitutions that are predicted to be benign. Secondary 
structure information was retrieved from a 3D structure for the cholesterol-binding domain (PDB ID: 3GKH) and predicted for the rest 
of the protein. Squared residues represent beta-sheet, while circles with outline stand for alpha helices. Disulphide bonds are 
represented (dashed lines) only for the cholesterol-binding domain. 
Figure 5-5 NPC1 missense mutation risk map. 
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5.5 Materials and Methods 
Databases, multiple sequence alignments and phylogenetic trees 
Human NPC1 protein (NM_000271.4) was queried through blastp (Altschul et al. 1990) 
against the human genome to reveal the related sequences. Each hit was blasted 
individually against the RefSeq database (Pruitt et al. 2012). For each job the full 
sequences were compiled and aligned using MAFFT default algorithm (Katoh and 
Standley 2013). Neighbor joining tree was built with the phylip package (Retief 2000). 
From the tree, the NPC1-homologs clade was isolated. With the retrieved homologs, 
MAFFT version v7.154b E-INS-i algorithm was used to realign the full-length sequences. 
A maximum-likelihood tree was constructed using the PhyML software version 20140929 
(Guindon et al. 2009), with JTT substitution model (Jones et al. 1992) and the remaining 
parameters as default. The outgroups that were not considered to be NPC1 homologs 
based on Refseq annotations and domain architectures were discarded from the multiple 
sequence alignment, NPC1 homologs were realigned and the final phylogenetic tree was 
built using the previously described approach.  
Taxonomic distribution 
After obtaining the final set of sequences, gene IDs were assigned to protein sequences 
using NCBI Entrez (Gibney and Baxevanis 2011). The gene counts were visualized on a 
taxonomically classified sunburst tree. Taxonomical ranks were taken from  the NCBI 
taxonomy database (Federhen 2012). Organisms were selected based on two criteria: (i) 
the availability of their NPC1 in the RefSeq database and (ii) the availability of their 
genome in the NCBI genome database. The sunburst visualization was performed with a 




Orthologs and paralogs were distinguished using the maximum likelihood phylogenetic 
tree. In case of major duplication events, a consistently more divergent duplicated clade 
was categorized as paralogs that are less likely to retain the original NPC1 function. The 
reference point for evolutionary distance was determined as the full-length NPC1 node. 
In the cases where no divergence consistency between clades was observed (e.g. not all 
species in clade A were more diverged than those in clade B, or incomplete species set 
in both clades), the orthology assignment was deemed inconclusive. In such cases, we 
considered both clades as paralogs that have a potential to gain a modified function. For 
the species-level duplications, the sequence, which was significantly diverged from the 
closest node of NPC1 orthologs, was categorized as paralogous.   
Scoring the effect of single amino acid variants 
 PubMed 1997-2014 database was manually searched to identify relevant studies and 
case series. The search key words used were: (i) “Niemann-Pick type C”, (ii) “NPC1”, (iii) 
“NPC1 mutations”. No other search restrictions were applied and all related reference 
articles were retrieved and reviewed. The initial search resulted in 312 papers. General 
review articles on Niemann-Pick disease type C pathogenesis, course and outcomes, 
basic clinical case reports lacking genetic testing and experimental findings not connected 
with clinical data were excluded. As a result, we identified 56 articles referencing a total 
of 572 mutations in the NPC1 gene (including repetitive reports). After refining this list by 
excluding repetitive reports, insertion/deletion, frameshift and nonsense mutations and 
benign SNPs, the final list of most likely pathogenic SAVs was comprised of 166 variants 
that were referred to as “damaging” variants in this study. In order to retrieve the set of 
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“benign” mutations, we used frequencies in human populations reported by Wassif et al. 
(Wassif et al. 2015). The variants found in humans with higher frequency than the most 
common deleterious variant, I1063T, were categorized as benign. However, we removed 
N222S, N961S, S1200G and A521S from this list, due to the reports suggesting that they 
might be damaging. 
In our algorithm, the “moderately variable” category was defined as a position having 
more than 5 different substitutions in a given set. Position was categorized as “hyper-
variable” if there were more than 9 different substitutions. 
Statistical analyses  
The performance of the algorithm is described by the following parameters: sensitivity, 
specificity, false discovery rate, accuracy, F1 score and Matthews Correlation Coefficient 
(MCC). In the equations given below, TP, TN, FP and FN refer to the number of true 
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Domain architecture prediction and risk map generation  
We used CDvist webserver with HMMER3 against Pfam 27.0 and HHsearch against PDB 
options respectively (Finn et al. 2014; Adebali et al. 2015). PDB HHsearch probability 
cutoff was adjusted to 98%. Transmembrane regions and signal peptides were predicted 
using Phobius (Kall et al. 2007). 
We implemented the SAVER algorithm in a python3 script and ran it on all theoretical 
human NPC1 SAVs. For each position, we counted the allowed (benign) amino acids. 
The range was between 0 (no substitution allowed) and 19 (any substitution allowed). For 
secondary structure information, X-ray crystal structure (PDB ID: 3GKH) was used for N-
terminal domain and Psipred prediction was used for the rest. Protter web application was 
used to generate the NPC1 membrane topology figure using default parameters for 
transmembrane region and signal-peptide predictions. Disulphide bond information for N-
terminal domain was also collected from the available structure. 
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Interpretation of the risk map 
Each residue in a protein experiences a different selection pressure due to their molecular 
function. Some residues are replaceable, and some cannot be altered. Additionally, there 
are positions allowing replacements by only certain amino acids. Though interchangeable 
amino acids usually share at least one physiochemical characteristic, this is not always 
the case.  
According to the NPC1 risk map (Figure 5-5), first two TM regions are not conserved as 
well as other TM regions. Thus, these two regions may not be involved in sterol transport 
process. Instead, they could have evolved as a simple connector to join lumenal 
cholesterol-binding domain with the rest of the protein. On the other hand, the rest of the 
TM regions show moderate to high level of conservation. Particularly, TM5, TM11, TM12 
and TM13 may play critical roles in the transport process. We also see heterogeneous 
high level of conservation in the lumenal domains. Predicted helices and beta sheets 
generally correlate with the conservation pattern. However, some predicted unstructured 
regions are also highly conserved. Specifically, most cysteine residues in the lumenal 
domains are invariable, likely because of their specific structural role of building disulfide 
bridges.  The cytoplasmic regions between TM5 and TM6, and TM11 and TM12 are 
predicted to form secondary structure elements and also are well conserved, which 
indicates that these regions may play a distinct functional role.  
The risk map built based on set 1 and set 2 shows evolutionary patterns that we already 
deduced from the MSA of all NPC1 homologs. For instance, TM1 and TM2 were 
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considered to function in linking cholesterol-binding domain with the rest, based on the 
analysis of domain architectures of NPC1 homologs in chromalveolata and Naegleria. 
Even these sequences are removed from the analysis, we can still observe a relaxed 
selection pressure on these regions, which also indicates that they are not functionally 
critical. Taken together these observations suggest that the evolutionary depth of the 
dataset, which includes only functional orthologs of NPC1, is sufficient to infer tolerant 




Close homologs are often missing from automatically constructed datasets, whereas functionally 
unrelated remote homologs might be present. A) The maximum likelihood phylogenetic tree of 
sequences from the alignment we generated based on raw sequences retrieved (February 15th, 
2015) from PolyPhen-2 (PP2) human NPC1 (Uniprot ID: O15118) query. B) Maximum-likelihood 
phylogeny of NPC1 homologs from the core alignment compiled in this study. Red markers 
identify sequences that are present in the PP2 alignment. The unmarked sequences are missing 
from the PP2 alignment. PTC1-2: Patched protein homolog 1-2, PTRs: Unclassified patched 
receptor like proteins, MRC1: Mannose receptor, C type 1. 
Figure 5-6 Common problems in automated prediction of functional effects of amino acid 




Green flags indicate the presence of a single NPC1 gene in associated genome, whereas red 
and black flags are representatives of two and more NPC1 copies respectively. Shaded clades 
have at least one NPC1 gene and white clades have no detectable NPC1 homologs. NPC1 is 
present in all four eukaryotic supergroups represented here. NPC1 and NPC1-L1 were found in 
all mammalians except for Bison bison. Although all avian genomes have NPC1, most of them 
are missing the NPC1-L1 gene. Except for mammals, NPC1-L1 is not consistently found in other 
classes of Chordata. In Actinopteri, we observed a loss of both genes in Salmoniformes, Esox 
lucius, Notothenia coriiceps and Ictalurus punctatus. In Anura, Xenopus tropicalis have both 
genes, but they both are missing from Xenopus laevis.    




Branch length means of clades were measured and subjected to t-test. Significance is 
represented by asterisk with p-value<0.0001. In C, the p-value was 0.04. 
  




Full version sequences include cholesterol-binding domain (blue). Short version NPC1 genes 
contain sterol-sensing and patched domains and no cholesterol-binding domain. Cholesterol-
binding domain is found as a single protein in chromalveolatan species as well as Naegleria 
gruberi. The cholesterol-binding domain protein exclusively coexist with the short version of 
NPC1. Oomycetes (such as Phytophthora parasitica) have both full and short versions of the 
NPC1 gene. 
  




The data is inferred from predictions on 166 damaging and 21 benign variants known in NPC1. 
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The main subjects of this work are protein sequences. Three aspects of proteins are 
covered here: (i) Identifying protein domain architectures; (ii) Finding functional partners 
of proteins; (iii) Evaluating importance of individual residues in protein function. With the 
increasing amount of genomic data, it is becoming more important to computationally 
identify cellular and molecular functions of proteins by using only sequences. To define a 
protein, looking into the domains that the protein contains is one of the initials steps. More 
often than not, researchers encounter proteins with no assigned domain for some regions, 
if not for the entire length of the protein. That’s why more sensitive domain assignment 
was a necessary task (chapter three). Secondly, while using the comparative genomics 
approach, obtaining the taxonomic distribution of the gene/protein of interest is another 
useful aim. However, displaying the distribution of sequences only in species where a 
particular protein is present constitutes only half of the story. Information on both 
presence and absence of proteins completes the phylogenetic profile. Additionally, 
visualizing multiple proteins on the same distribution frame is helpful to understand their 
coevolution patterns, if there are any. By introducing such features in the field of 
bioinformatics, it becomes possible to learn more about evolutionary history and 
functional interactions of proteins (chapter four). Finally, identifying amino acids that are 
functionally important in a protein was an important task as it has a wide applicability in 
research and clinics. A general approach is to examine the conservation patterns of 
individual amino acids. However, with this traditional approach does not provide the 
desired level of accuracy (mostly because of insensitivity) in predicting damaging 
variants. This is likely due to the noise introduced by the non-related or neo-functionalized 
paralogous proteins, which were likely to have the same function as the protein of interest. 
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Analyzing evolutionary history thoroughly with the phylogenetic approach helped in 
distinguishing between diverged paralogs and orthologs. By considering only orthologs, 
the quality of the alignment increases, yielding a better assessment of conserved residues 
in the MSA of functionally equivalent sequences (chapter five).  
6.1 Implications of the Covered Work for the Present and the Future 
6.1.1 Protein domain assignment 
The first work in this dissertation was building the CDvist algorithm and web server. The 
goal of developing CDvist was to accelerate the discovery of novel domains and 
improving overall domain coverage in protein sequences. Despite the wide popularity and 
success of domain identification tools and databases, as of today, at least 30% of the 
protein sequence space (all sequences in the non-redundant database) has no domain 
coverage. By providing a logical, flexible and iterative pipeline for domain search, rich 
visualization, and bulk querying, we expected CDvist to attract both biologists and 
bioinformaticians. As of January 2015, since the manuscript was published, more than 
3000 users visited the CDvist website with ~4000 sessions.  CDvist has become of 
interest to researchers dealing with proteins with no identified domain with standard 
techniques. Also, users having batch queries use the tool to perform more sensitive 
domain identification through HHsearch on multiple queries at once. With the help from 
users contacting us, we tailored the web server according to their needs. We expect that 
this kind of integration of ideas helps a variety of research groups. For this reason, it is 
important that administrators of this kind of research web server should be accessible, 
responsive and prepared to fulfill the needs of the community. 
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CDvist works on subsequences rather than the entire sequence. Subsequences are 
redefined after every iteration that comes with a significant hit. Performing HHsearch with 
a number of small units takes time and that’s why the CDvist process is slow for a single 
sequence submission. The tool compensates this disadvantage by offering linear speed-
up for batch requests using a supercomputer, Newton High-Performance Cluster in the 
University of Tennessee. In other words, CDvist users all around the world utilize a 
supercomputer from their home.  
Users of CDvist are offered a number of options for domain search. It is possible to 
manually choose the databases of interest in the desired order. Also, since the best 
domain hit (if it is beyond the significance threshold) is assigned to the protein each time, 
the domain assignment and the following subsequence definition depend heavily on the 
determined significance threshold. The order of the databases changes the entire result 
of domain architecture. If a user starts with Pfam followed by CDD, it means that the user 
gives more importance to Pfam and refers to CDD only to find domains for the regions 
that couldn’t be covered by Pfam. The domain architecture found first by CDD followed 
by Pfam would be different in a sense that the order of tools would be opposite to the 
case above. For this reason, there is no standard procedure to search protein domains 
with CDvist. The pipeline can be tailored according to each user’s need. That’s why pre-
computed CDvist results cannot be offered for now. If a concept that rationalizes a 
standard procedure is developed, then that CDvist pipeline can be applied to a vast 
amount of protein data. Only if there is such a standardized procedure, it would be 
reasonable to dedicate computer hours to perform CDvist search on the protein universe, 
after which pre-computed domain assignments would be retrieved at a high speed. 
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It is predicted that, if the domain discovery rate stays still, domain databases will cover 
the complete protein universe in the next 20-30 years. Until that point, CDvist is likely to 
help in this effort.  
6.1.2 Using the Positives and Negatives of Multidimensional Data 
Humans have extraordinary ability in pattern recognition. We use this ability to conceive 
the facts. In molecular biology, although the data is concrete, it is not always easy to 
visualize. Especially for large sets of genomic data, researchers tend to cluster data and 
display representatives instead of visualizing everything. With Aquerium, we offer a 
platform for visualization of multi-layer genomic information. Among comparative 
genomics methods, particularly phylogenetic profiling is appropriate to be applied on such 
a platform displaying thousands of genomes with their multi-layer information.  
One important missing piece in visualizing molecular data on genomics level is to display 
negative data. Since it is challenging to display what is absent in genomes, it has been 
ignored by the bioinformatics community. Aquerium handles genomic absence 
information. Although single absences are not confidently categorized as true, multiple 
independent co-absences are important indicators of true negatives. 
Aquerium uses the taxonomic information to cluster related organisms. Although this 
classification is useful, it is limited in identifying relationships between taxons which have 
no hierarchical discrimination between them. For instance, relationships between species 
belonging to the same genus cannot be determined if there is no middle rank between 
the species and the genus rank. Therefore, presence and absence data in these kinds of 
genomes may misleadingly seem as independent events. To solve this problem, a 
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phylogenetic tree of life should be built to guide neighboring genomes that are closer to 
each other. However, building the tree of life is not straightforward, and there is a 
substantial effort on this subject in computational biology.  
Phylogenetic profiling is usually applied for genes/proteins that are suspected to be 
involved in the same biochemical network. This method is used to verify protein-protein 
interactions as an additional line of evidence from the genomics point of view. However, 
this approach can also be used as a hypothesis generating method in discovering 
potentially interacting genes/proteins by building phylogenetic profiles of proteins and 
domains and compare them with each other. Aquerium already contains a database of 
domain-linked genomes. This database can easily be converted to a genome-linked 
domain database. This database should include domain records, each of which contains 
a genomic occurrence pattern (profile). Because taxonomic classification can provide a 
sensitivity up to a certain limit, the phylogenetic tree of life will be crucial when building 
precise profiles. Phylogenetic profiles of domains can be compared to each other to 
reveal common co-occurrence patterns which would be the indicators of potentially 
interacting domains. Using only Pfam (v.28) domains, the analysis would result in 256 
million pairwise comparisons, which is a solvable problem in computational biology. 
6.1.3 Phylogenetics Matter in Health and Disease 
Predicting the effects of mutations in genetic diseases is one of the hot topics of 
computational biology, with direct applications in personalized medicine, risk estimation 
etc. We brought up a new concept in this prediction algorithm: using precise evolutionary 
histories of genes. Building high-quality evolutionary history is challenging as there is no 
standard automated procedure to establish it. However, every automation begins with 
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primary concepts manually proved to work in test cases. In chapter five, we present such 
a test case with new ideas on how to assess single amino acid variants. The major point 
of the work was to distinguish orthologs from paralogs. We defined criteria on how to 
perform such a task through phylogenetic analysis. Also, new functions in isoform 
handling and MSA cleaning were introduced. Moreover, a new evolutionary parameter 
“event number” was defined and used in the algorithm. We think that these new 
approaches should be taken into consideration by the community dealing with mutation 
outcome prediction. 
Although the introduced concepts worked for the NPC1 case, it should be tested in other 
Mendelian diseases as well. Especially, the genes with different patterns of evolutionary 
history should be tested. As a first step, our manual work can be performed on ~600 well-
known Mendelian diseases. Phylogenetic trees for this set should be built and analyzed. 
After testing the genes with diverse evolutionary patterns, it would be possible to 
automate the approach and algorithm to apply to any protein. The SAVER algorithm 
should be exposed to machine learning and trained with a benchmark data set. By training 
the algorithm, SAVER can produce a continuous spectrum of scores between benign and 
damaging instead of binary outputs. This way, the results will be biologically more 
meaningful because some mutations may have subtle effects where others may result in 
function loss or neutral change. 
As a side product, the phylogenetic analysis was proved useful in the assignment of 
orthologs and paralogs. For this reason, phylogenetics should be adopted by orthology 
databases. The current methods in these databases are generally based on pairwise 
comparisons and/or MSAs converted into distances. However, as discussed in the 
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introduction, phylogenetic analysis provides a better resolution in discriminating orthologs 
from paralogs. 
6.2 Scripting for Genomics 
This work resulted in a number of scripts, packages and databases as side products. A 
small portion of them was polished and made available to public with a user-friendly 
graphical interface. However, most of them still remain in private depositories and are not 
available to the public. Unpublished scripts produced in this work were not crucial for final 
products of the projects, however, they were very useful in working with genomic data. In 
an ideal world, researchers should benefit from each other’s work, and programming code 
to make progress in science. Reinventing the wheel would be a waste of time, money and 
labor. Therefore, as computational biologists, we should make our resources available to 
anyone. GitHub and BitBucket are appropriate repository hosting services.   
JavaScript/HTML5 is a good scripting platform for not only presenting data to public but 
also understanding genomic data for in-house usage. Jquery and D3 are game-changer 
JavaScript packages as they established new ways of coding. Moreover, browser 
extensions written in JavaScript are highly useful to add external lines of information on 
the existing web servers such as BLAST. These packages should be made available to 
the public. However, the small visualization packages are often not worth to prepare for 
publishing. I believe that there should be a journal dedicated to small application notes 
for genomic data visualization. Therefore, researchers who build their in-house 




6.3 Final Remarks 
This dissertation showed how considering molecular evolution helps in understanding the 
functions of the proteins overall and on the residue-level. Diversity is achieved through 
evolution while conserving the most important parts for survival at the molecular level. 
Genes are derived from each other and all genes could have had a single common 
ancestor. Although sequence data are too diverged to achieve the universal common 
ancestor, it is still useful to infer relatively recent relationships among them. This 
homology information helps greatly in understanding molecular biology, eventually 
leading to a solid understanding of cellular and even organismal levels of life. Through 
evolution, genes that are not viable have already been eliminated. Therefore, what we 
observe in the evolution of genes and organisms can be used as a guide to understanding 
what changes were allowable. 
There is still a lot to be discovered from sequences that are already available. Because 
sequence data contains more than one type of information, a variety of techniques are 
applied to understand more about gene functions, protein structures, disease tendency 
etc. Every method/approach developed in this field has different aims and priorities. In 
other words, there is no such an optimal algorithm for a biological question. Every different 
case is evaluated afresh by computational biologists. While biologists can use 
bioinformatics tools for simple tasks, a stronger computational expertise is required to 
analyze large data sets. To conclude, in order to perform large-scale bioinformatics 
analysis, computational programs, resources and power are necessary but insufficient 
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